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A B S T R A C T
Background
Patients with high blood pressure (hypertension) in the community frequently fail to meet treatment goals - a condition labelled as
“uncontrolled” hypertension. The optimal way to organize and deliver care to hypertensive patients has not been clearly identified.
Objectives
To determine the effectiveness of interventions to improve control of blood pressure in patients with hypertension. To evaluate the
effectiveness of reminders on improving the follow-up of patients with hypertension.
Search methods
All-language search of all articles (any year) in the Cochrane Controlled Trials Register (CCTR) andMedline; and Embase from January
1980.
Selection criteria
Randomized controlled trials (RCTs) of patients with hypertension that evaluated the following interventions:
(1) self-monitoring
(2) educational interventions directed to the patient
(3) educational interventions directed to the health professional
(4) health professional (nurse or pharmacist) led care
(5) organisational interventions that aimed to improve the delivery of care
(6) appointment reminder systems
Outcomes assessed were:
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(1) mean systolic and diastolic blood pressure
(2) control of blood pressure
(3) proportion of patients followed up at clinic
Data collection and analysis
Two authors extracted data independently and in duplicate and assessed each study according to the criteria outlined by the Cochrane
Handbook.
Main results
72 RCTs met our inclusion criteria. The methodological quality of included studies varied. An organized system of regular review
allied to vigorous antihypertensive drug therapy was shown to reduce systolic blood pressure (weighted mean difference (WMD) -
8.0 mmHg, 95% CI: -8.8 to -7.2 mmHg) and diastolic blood pressure (WMD -4.3 mmHg, 95% CI: -4.7 to -3.9 mmHg) for three
strata of entry blood pressure, and all-cause mortality at five years follow-up (6.4% versus 7.8%, difference 1.4%) in a single large
RCT- the Hypertension Detection and Follow-Up study. Other interventions had variable effects. Self-monitoring was associated with
moderate net reduction in systolic blood pressure (WMD -2.5 mmHg, 95% CI: -3.7 to -1.3 mmHg) and diastolic blood pressure
(WMD -1.8 mmHg, 95% CI: -2.4 to -1.2 mmHg). RCTs of educational interventions directed at patients or health professionals were
heterogeneous but appeared unlikely to be associated with large net reductions in blood pressure by themselves. Nurse or pharmacist
led care may be a promising way forward, with the majority of RCTs being associated with improved blood pressure control and mean
SBP and DBP but these interventions require further evaluation. Appointment reminder systems also require further evaluation due
to heterogeneity and small trial numbers, but the majority of trials increased the proportion of individuals who attended for follow-
up (odds ratio 0.41, 95% CI 0.32 to 0.51) and in two small trials also led to improved blood pressure control, odds ratio favouring
intervention 0.54 (95% CI 0.41 to 0.73).
Authors’ conclusions
Family practices and community-based clinics need to have an organized system of regular follow-up and review of their hypertensive
patients. Antihypertensive drug therapy should be implemented by means of a vigorous stepped care approach when patients do not
reach target blood pressure levels. Self-monitoring and appointment reminders may be useful adjuncts to the above strategies to improve
blood pressure control but require further evaluation.
P L A I N L A N G U A G E S U M M A R Y
What interventions improve the control of high blood pressure
There is little evidence as to how care for hypertensive patients should be organized and delivered in the community to help improve
blood pressure control. This review aimed to determine the effectiveness of interventions whose objective was to improve follow-up
and control of blood pressure in patients taking blood pressure lowering drugs. We included studies that had as population of interest
adult patients with essential hypertension in an ambulatory setting. The interventions included all those that aimed to improve blood
pressure control. The outcomes assessed were mean systolic and diastolic blood pressure, control of blood pressure and the proportion
of patients followed up at clinic.
Seventy two randomised controlled trials met our inclusion criteria. The range of interventions used included (1) self-monitoring,
(2) educational interventions directed to the patient, (3) educational interventions directed to the health professional, (4) health
professional (nurse or pharmacist) led care, (5) organizational interventions that aimed to improve the delivery of care, (6) appointment
reminder systems. The trials showed a wide variety of methodological quality, part of which may be attributed to poor reporting. An
organized system of regular review allied to vigorous antihypertensive drug therapy was shown to reduce blood pressure and all-cause
mortality in a single large RCT- the Hypertension Detection and Follow-Up study. Other interventions had variable effects. Weighted
data analysis showed that self-monitoring was associated with moderate net reductions in systolic blood pressure (weighted mean
difference -2.5 mmHg, 95% CI: -3.7 to -1.3 mmHg) and diastolic blood pressure (weighted mean difference -1.8 mmHg, 95% CI:
-2.4 to -1.2 mmHg). Trials of educational interventions directed at patients or health professionals were heterogeneous but appeared
unlikely to be associated with large net reductions in blood pressure by themselves. Nurse or pharmacist led care may be a promising
way of improving control in patients with hypertension, with the majority of RCTs being associated with improved blood pressure
control, improved systolic blood pressure and more modestly improved diastolic blood pressure, but these interventions require further
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evaluation. Appointment reminder systems increased the proportion of individuals who attended for follow-up (absolute difference
16%, but this pooled result should be treated with caution because of the heterogeneous results from individual RCTs) and in two
small trials also led to improved blood pressure control, odds ratio favouring intervention 0.54 (95% CI 0.41 to 0.73).
We conclude that an organized system of registration, recall and regular review allied to a vigorous stepped care approach to antihy-
pertensive drug treatment appears the most likely way to improve the control of high blood pressure. Health professional (nurse or
pharmacist) led care and appointment reminder systems requires further evaluation. Education alone, either to health professionals or
patients, does not appear to be associated with large net reductions in blood pressure.
B A C K G R O U N D
High blood pressure (hypertension) is an important public health
problem in terms of associated stroke and cardiovascular events.
It is mostly of unknown aetiology, is easy to diagnose and is
readily preventable by blood pressure reduction. Extensive epi-
demiological data have strengthened the well-recognised relation-
ship between blood pressure and cardiovascular disease risk and
have confirmed the importance of systolic BP as a determinant
of risk (Prospective Studies Collaboration 2002). Evidence from
randomized trials has shown that effective drug treatment re-
duces the risk of cardiovascular morbidity and mortality (Collins
1994; Gueyffier 1999). However, there is ongoing concern that
the benefits demonstrated in randomized trials of antihypertensive
drug treatment are not implemented in everyday clinical practice
(Burnier 2002). Community-based studies throughout the world
show that blood pressure goals are achieved in only 25 to 40% of
the patients who take antihypertensive drug treatment (Burnier
2002; Hyman 2001; Chobanian 2001; Smith 1990), a situation
that has remained unchanged for the last 30 years (Wilber 1972).
The quality of care patients with hypertension receive from health
professionals has a clear impact on their risk of suffering a car-
diovascular event. Observational studies in the UK have shown
that inadequate control of blood pressure and poor follow-up is
associated with a significant risk of stroke and avoidable vascular
deaths (Du 1997; Payne 1993). In terms of the process of care that
hypertensive patients receive, characteristics of the patient, health
professional and the healthcare system in which they are given
their medical care have been implicated in poor blood pressure
control. Lack of adherence tomedication and not having a primary
care physician were associated with poor blood pressure control
in a US study (Shea 1992). More recent studies have shown that
frequent contact with health care professionals does not guarantee
better blood pressure control unless there is more vigorous use of
antihypertensive drugs (Hyman 2001; Berlowitz 1998), and that
individual practitioners vary substantially in their clinical perfor-
mance when managing hypertension in the community (Frijling
2001). These observations have led some commentators to suggest
that poor control of blood pressure in the community may be due
to ineffective management and inadequate practice organisation,
described jointly as “clinical inertia” (Phillips 2001). Use of self
monitoring of blood pressure by patients and professionals has
gained popularity and is now recommended in certain patients in
some national and international guidelines. A recentmeta-analysis
of randomised trials on the subject did suggest a benefit in terms
of mean blood pressure and blood pressure control (Cappuccio
2004).
Whilst there is a strong evidence-base for the benefits of anti-
hypertensive drug therapy (Collins 1994; Blood 2000; Staessen
2001), there is little clear evidence as to how care for hypertensive
patients should be organized and delivered in the community to
help improve blood pressure control. This systematic review aims
to update and build upon previous reviews (Ebrahim 1998; Fahey
2006), to summarize the evidence from randomized controlled
trials that evaluate different models of care that have been used to
improve the control and follow-up of patients with hypertension.
O B J E C T I V E S
The objectives of this review are to:
(1) Evaluate which models of care are effective in improving “con-
trol” of high blood pressure;
(2) Evaluate the effectiveness of reminders on improving the fol-
low-up of patients with hypertension.
M E T H O D S
Criteria for considering studies for this review
Types of studies
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Randomized trials of interventions that have sought to evaluate
different models of care for patients with hypertension with the
overall aim of improving blood pressure control or follow-up care
of patients. Included studies had to be RCTswith a contemporane-
ous control group where patient care in the intervention group(s)
was compared with either no intervention or usual care. We ex-
cluded studies using interventions not intended to increase blood
pressure control by organisational means, particularly drug trials
and trials of non-pharmacological treatment.
Types of participants
The populationof interestwas composed of adult patients (aged 18
years or over) with essential hypertension (treated or not currently
treated with blood pressure lowering drugs) in a primary care,
outpatient or community setting.
Types of interventions
The interventions were aimed at improving control of blood pres-
sure or clinic attendance and were classified as:
(1) self-monitoring
(2) educational interventions directed to the patient
(3) educational interventions directed to the health professional
(4) health professional (nurse or pharmacist) led care
(5) organisational interventions that aimed to improve the delivery
of care
(6) appointment reminder systems
Types of outcome measures
Studies were included if they reported:
(1)mean systolic bloodpressure (meanSBP) and/ormean diastolic
blood pressure (mean DBP)
(2) control of blood pressure (blood pressure threshold that deter-
mines “control” being pre-specified or defined by each random-
ized trial’s investigators)
(3) proportion of patients followed-up at clinic
Search methods for identification of studies
The following electronic databases were searched for primary stud-
ies:
a) The Cochrane Central Register of Controlled Trials (2007,
Issue 4)
b) English language databases, including MEDLINE (1950-
February 2008) and EMBASE (1980-February 2008).
Electronic databases were searched using a strategy combining a
variation of the Cochrane Highly Sensitive Search Strategy for
identifying randomized trials in MEDLINE: sensitivity-maximiz-
ing version (2008 revision) with selected MeSH terms and free
text terms relating to hypertension. No language restrictions were
used. TheMEDLINE search strategywas translated into the other
databases using the appropriate controlled vocabulary as applica-
ble. Full strategies for all English language databases are included
in Appendix 1, Appendix 2, Appendix 3.
Other sources:
c) Reference lists of all papers and relevant reviews identified
d) Authors of relevant paperswere contacted regarding any further
published or unpublished work
e) Authors of trials reporting incomplete information were con-
tacted to provide the missing information
f ) ISI Web of Science was searched for papers that cite studies
included in the review
Data collection and analysis
Two of the authors (LG and AM) assessed lists of citations and
abstracts independently. We were not masked with regard to au-
thors or journal. Each reviewer indicated whether a citation was
potentially relevant (i.e. appearing to meet the inclusion criteria),
was clearly not relevant, or gave insufficient information to make
a judgement. To be included, a study had to meet all the inclu-
sion criteria. We (LG and AM) resolved differences by discussion
and final adjudication was performed by TF and SS. We obtained
reprints of all potentially relevant citations
We (LG and AM) independently extracted data in duplicate on
study design, methods, clinicians and patients, interventions, out-
comes and potential sources of bias using a structured data col-
lection form. We wrote to the corresponding authors of studies
to request missing data, clarify study details and enquire about
unpublished studies.
For assessment of study quality, we collected data on inclusion
and exclusion criteria; randomization procedure; allocation con-
cealment; blinding of participants, providers of care and outcome
assessors; and losses to follow-up (Clarke 2000).We also identified
those studies that used a cluster design, which has the potential
for unit of analysis errors, and performed a sensitivity analysis ex-
cluding those studies which may have been analyzed incorrectly.
We examined the effects on blood pressure between interven-
tions at follow-up (systolic and diastolic blood pressure) accord-
ing to the six pre-defined intervention categories. We compared
and pooled the mean blood pressure differences from baseline to
final follow-up in the intervention and control groups using the
weighted mean difference approach (see Cochrane Heart Group
web site: http://www.epi.bris.ac.uk/cochrane/stats3.html). When
only partial information about the variance was provided in RCT
reports, we calculated variances using the method described by
Follman (Follman 1992). We have taken account of the correla-
tion of baseline and final blood pressure measurements by using
empirical data from the Caerphilly data set which examined the
correlation between baseline and 5-year follow-up blood pressure
measurements in 2000 men (r=0.568 for systolic and r=0.514 for
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diastolic blood pressure) (personal communication Margaret May,
Department of Social Medicine, University of Bristol).
For blood pressure control and clinic attendance at follow-up,
statistical and clinical significance was evaluated by means of es-
timating odds ratios with 95% confidence intervals. Individual
study definitions of control of blood pressure and attendance at
clinic were used. For both continuous and categorical outcomes,
we checked the meta-analyses for heterogeneity by visual inspec-
tion and by Cochran’s test. When heterogeneity is significant, the
individual study results are presented to illustrate the magnitude
of blood pressure reduction reported but no overall pooled results
are presented. Pooled odds ratios and their 95% confidence inter-
vals were calculated with The Cochrane Collaboration RevMan 5
software.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Seventy two unique randomized controlled trials met the inclu-
sion criteria. Four of these trials had single or multiple compan-
ion publications or studies associated with them (Levine 1979
and Morisky 1983; Hypertension 1979 Hypertension 1979a and
Hypertension 1982; Hetlevik 1998 and Hetlevik 1999; Takala
1979 and Takala 1983) giving a total of 77 studies included in
the analysis. Four randomised controlled trials had a factorial de-
sign and are included twice under separate intervention headings -
Hennessy (education- health professional and education- patient)
(Hennessy 2006), Pierce (self-monitoring and education- patient)
(Pierce 1984), Sackett (education- patient and organisation of
care) (Sackett 1975), and Dickinson (education- health profes-
sional and organisation of care) (Dickinson 1981). There were
also two three-armedRCTs: one of a telephone reminder, a mailed
reminder and usual care (Contreras 2005) and a second of patient
education, home monitoring from a family member actively par-
ticipating in their care and a usual care arm (Earp 1982). Of the
seventy two randomized controlled trials that met the inclusion
criteria, 14 used a cluster design (Dickinson 1981; Evans 1986;
Gullion 1987; Hetlevik 1998; Hetlevik 1999; McAlister 1986;
Montgomery 2000; New 2004; Ornstein 2004; BaquÄö 2005;
Hennessy 2006;Marquez 2004;McManus 2005; Turnbull 2006).
In four of these, no adjustment was made for clustering effect
(Evans 1986; Dickinson 1981; Gullion 1987; Turnbull 2006) and
in two of these trials we could not ascertain whether adjustment
was made for clustering effect (BaquÄö 2005; Marquez 2004).
Thus we identified six trials as having potential unit of analysis
errors. A sensitivity analysis excluding those studies did not sig-
nificantly alter our main results below.
Risk of bias in included studies
The reported methodological quality of included studies was gen-
erally poor tomoderate. The randomization process was described
in thirty (42%) of the seventy two trials included whilst only four-
teen (19%) had adequate allocation concealment (Figure 1). In 15
studies (21%) the outcome assessors were blind to the treatment
allocation and losses to follow-up of 20% or more occurred in 18
(25%) of studies.
Figure 1. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
For a detailed summary of each of the 72 included RCTs, see Table
1.
Effects of interventions
(1) Self-monitoring (n=18RCTs) (McManus 2005; BaquÄö2005;
Halme 2005;Pierce 1984; Bailey 1998; Carnahan 1975; Friedman
1996; Haynes 1976; Johnson 1978; Mehos 2000; Rogers 2001;
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Soghikian 1992; Vetter 2000; Zarnke 1997; Artinian 2001;
Midanik 1991; Rudd 2004; Earp 1982).
Pooled data from 12 RCTs that reported on differences in mean
SBP (Halme 2005; McManus 2005; Carnahan 1975; Soghikian
1992; Friedman 1996; Bailey 1998; Mehos 2000; Vetter 2000;
Rogers 2001; Artinian 2001; Midanik 1991; Rudd 2004) showed
that self-monitoring was associated with a significant reduction of
-2.5 mmHg (95% confidence intervals (CI): -3.7 to -1.3 mmHg).
However significant between-group heterogeneity for mean SBP
(range -10 to +5mmHg) was apparent in this group of stud-
ies. Pooled data from 14 RCTs on difference of mean DBP
(Carnahan 1975; Soghikian 1992; Friedman 1996; Bailey 1998;
Mehos 2000; Vetter 2000; Rogers 2001; Haynes 1976; Johnson
1978; Artinian 2001; Midanik 1991; Rudd 2004; McManus
2005; Halme 2005),showed that self-monitoring was associated
with amoremodest reduction of -1.8mmHg (95%CI -2.4 to -1.2
mmHg). In the sixRCTs that reported on control of bloodpressure
(Pierce 1984,Rogers 2001; Vetter 2000; Earp 1982; BaquÄö 2005;
Halme 2005), there was no significant improvement in blood pres-
sure control seen (odds ratio 0.97, 95% CI 0.81 to 1.16). The
remaining RCT that did not report any usable data concerning
blood pressure control, reported a mean arterial blood pressure
difference of 3mmHg in favour of the intervention (Zarnke 1997).
However, this RCT was of a short duration (8 weeks follow-up).
(2) Educational interventions directed to the patient (n=20 RCTs)
(Pierce 1984; Sackett 1975; Billault 1995; Burrelle 1986; Earp
1982; Fielding 1994; Gullion 1987; Hamilton 1993; Martinez-
Amenos 1990; Morisky 1983; Muhlhauser 1993; Roca-Cusachs
1991; Tanner 1981; Watkins 1987; Webb 1980; Zismer 1982;
Cakir 2006; Hennessy 2006; Hunt 2004; McKinstry 2006).
Eleven RCTs reported mean difference SBP, thirteen RCTs re-
ported mean difference DBP, and seven reported BP control. For
mean difference in SBP and DBP outcomes, pooling of results
from individual RCTs produced heterogeneous results, so pooled
mean differences are not valid. The reported mean difference in
SBP ranged from -15.7 mmHg to +1.3 mmHg, and mean differ-
ence in DBP was reported with a range from -8.7 mmHg to +7.1
mmHg. In terms of blood pressure control (eight RCTs), there
was a trend towards improved blood pressure control and this was
significant (odds ratio 0.83, 95% CI 0.75 to 0.91). Three RCTs
did not report relevant outcome data (Gullion 1987; Hamilton
1993; Martinez-Amenos 1990), but did report increases in pa-
tient knowledge (Martinez-Amenos 1990). Two of these RCTs
reported no difference in blood pressure control (Gullion 1987;
Martinez-Amenos 1990). One RCT reported an improvement in
SBP but not DBP at six months follow-up (Hamilton 1993).
(3) Educational interventions directed to the physician (n=10
RCTs) (Dickinson 1981; Coe 1977; Evans 1986; Hetlevik 1999 ;
McAlister 1986; Montgomery 2000; Ornstein 2004; New 2004;
Sanders 2002; Hennessy 2006).
Educational interventions directed towards the physician were not
associated with a significant decrease in mean SBP (mean differ-
ence -0.4 mmHg, 95% CI -1.1 to +0.2 mmHg) or DBP (mean
difference -0.4 mmHg, 95% CI -1.1 to +0.3 mmHg) whilst con-
trol of blood pressure produced heterogeneous results (odds ratio
ranged from 0.8 to 1.0).
(4) Health professional (nurse or pharmacist) led care (n=12
RCTs) ( Bogden 1998; Garcia-Pena 2001; Hawkins 1979; Jewell
1988; Logan 1979; Park 1996; Solomon 2002; de Castro 2006;
Schroeder 2005; Sookaneknun 2004; Tobe 2006; Tonstad 2007).
Health professional (nurse or pharmacist) led care may be a
promising way of delivering care, with the majority of RCTs be-
ing associated with improved blood pressure control. For all three
outcomes, pooling of results from individual RCTs produced het-
erogeneous results, so pooled mean differences may not be valid.
Mean difference in SBP was reported in ten RCTs with a range
of difference in mean SBP from -13 mmHg to 0 mmHg. Mean
difference in DBP was reported in eleven RCTs, ranging from -
8 mmHg to 0 mmHg. Control of blood pressure was reported in
six RCTs and produced heterogeneous results (odds ratio ranged
from 0.1 to 0.9).
(5) Organisational interventions that aimed to improve the de-
livery of care (n=9 RCTs) (Sackett 1975; Dickinson 1981; Brook
1983; Bulpitt 1976; Hypertension 1979; Hypertension 1979a;
Hypertension 1982; Robson 1989; Takala 1979; Takala 1983;
Turnbull 2006; Wetzels 2007).
For all three outcomes, pooling of results from individual RCTs
produced heterogeneous results, so pooled mean differences may
not be valid and the range of mean difference in SBP and DBP
is illustrated in MetaView. Of note, the largest RCT, the Hyper-
tension Detection and Follow-Up Program (HDFP), produced
substantial reductions in SBP and DBP across the three groups
in this RCT (patients were stratified according to level of entry
DBP level, weightedmean difference -8.2/-4.2mmHg, -11.7/-6.5
mmHg, -10.6/-7.6 mmHg for the three strata of entry blood pres-
sure) ). At five year follow-up, these reductions in blood pressure
were associated with a significant reduction in all-cause mortality
(6.4% versus 7.8%, risk difference 1.4%). Two RCTs did not re-
port relevant outcome data (Robson 1989; Brook 1983), but one
did report improved recording of blood pressure (Robson 1989).
(6) Appointment reminder systems (n=8 RCTs) (Ahluwalia 1996;
Barnett 1983; Bloom 1979; Cummings 1985; Fletcher 1975;
Krieger 1999; Contreras 2005; Marquez 2004).
In five RCTs, reminder systems were associated with an improve-
ment in follow-up. One RCT of a mailed postcard reminder was
not associated with improved follow-up (Ahluwalia 1996). The
pooled results though favouring appointment reminder systems
for follow-up of patients (odds ratio of being lost to follow-up 0.4,
95%CI 0.3 to 0.5) are heterogenous because of the single outlying
RCT and the pooled results should be treated with caution. Four
other RCTs (studies classified under the other intervention head-
ings but incorporated some form of reminder intervention such
as postal reminders or computer generated feedback) were associ-
ated with significantly improved follow-up attendance by patients
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(Dickinson 1981; Hamilton 1993; Hawkins 1979; Takala 1979;
Takala 1983). Pooled data from two small RCTs, one a three-
armed study of telephone reminder, mailed reminder and usual
care (Contreras 2005) and the other a parallel study of SMS re-
minder versus usual care (Marquez 2004) gave heterogenous re-
sults in terms of systolic and diastolic blood pressure but did show
a significant improvement in blood pressure control, odds ratio
0.54 (95% CI 0.41to 0.73).
D I S C U S S I O N
Key findings from this review
The main finding from this systematic review is to a large extent
dominated by the findings from the largest RCT, theHDFP study
(Hypertension 1979; Hypertension 1979a; Hypertension 1982).
Though partly intended as a trial to assess the value of systematic
identification of hypertensive patients (Davis 2001), the key ingre-
dients of how patients with established hypertension and taking
antihypertensive drug treatment weremanaged- free care, registra-
tion, recall and regular review in tandem with a rigorous stepped
care approach to antihypertensive drug treatment- should be em-
phasized as this multi-faceted intervention was effective in terms
of reaching blood pressure goals and reducing all-cause mortal-
ity. It is interesting to note that a two-year post trial surveillance
study showed that blood pressure control was attenuated when
the stepped-care arm of the study was discontinued. This lack of
control was associated with a decline in the use of antihypertensive
medication (Hypertension 1986).
The other significant finding from this review is that self-moni-
toring was associated with a decline in systolic blood pressure (2.5
mmHg) and diastolic blood pressure (1.8 mmHg). Although this
blood pressure reduction does not appear substantial in clinical
terms, it appears to be nonetheless a useful adjunct to care and is
likely to lead to a reduction in cardiovascular events. Further eval-
uation in larger RCTs and prospective studies including cardiovas-
cular outcomes are warranted. Other interventions assessed in this
systematic review did not produce clear results. None of the other
interventions were associated with large, clinically important, re-
ductions in either systolic or diastolic pressure, see MetaView. Ed-
ucation alone, directed either to patients or health professionals
appears unlikely to influence control of blood pressure as a sin-
gle intervention, as results were highly heterogeneous or of mar-
ginal clinical importance. Use of health care professionals such as
nurses and pharmacists, though producing significantly heteroge-
neous results, did have mainly favourable effects, and merit fur-
ther definitive evaluation in larger RCTs. Lastly, reminders (postal,
computer or telephone based) were associated with an improve-
ment in the follow-up and control of patients with hypertension
but produced heterogeneous results in terms of systolic and dias-
tolic blood pressure. This finding is consistent with the organisa-
tional structure of the HDFP study and re-iterates the importance
of systematic recall systems when organising care for hypertensive
patients.
Context of other studies
There are elements identified from this review that appear to be as-
sociated with improved blood pressure control and are consistent
with findings from observational studies and previous systematic
reviews. In a large community-based study, patients who received
intensive antihypertensive drug therapy were significantly more
likely to have reduced systolic blood pressure of 6.3 mmHg com-
pared to an increase of 4.8mmHg in those who received less inten-
sive antihypertensive drug therapy (Berlowitz 1998). A more re-
cent observational study showed that antihypertensive drug ther-
apy was initiated or changed in only 38% of episodes of care,
despite documented uncontrolled hypertension for at least six
months (Davis 2001; Oliveria 2002). Lack of practice organisa-
tion is associated with a failure to achieve treatment surrogate goals
in hypertension, diabetes and secondary prevention of coronary
heart disease (Phillips 2001). A recent systematic review of self
monitoring also produced similar findings of modest but poten-
tially important benefit in systolic and diastolic blood pressure
(Cappuccio 2004 errat). This is important in light of the fact that
self monitoring is now practiced by up to two thirds of the hyper-
tension population in the US and Europe (Pickering 2008). We
have found substantially more RCT evidence in terms of hyper-
tension management than a recent systematic review that exam-
ined interventions used in disease management programmes for
patients with chronic illness (Weingarten 2002). In that review,
eight hypertension-related RCTs were cited, which provided some
evidence of benefit in terms of education directed at the patient
and provider (health professional) (Weingarten 2002). In this sys-
tematic review of 72 RCTs, the subset of RCTs where the inter-
vention was directed at the patient (n=20) or physician (n=10)
does not support this finding, showing no clinically important ev-
idence for patient or health professional education as an effective
implementation strategy in the management of hypertension.
Study limitations
There are several shortcomings that need to be highlighted in this
systematic review. The HDFP study was designed as an interven-
tion that would identify newly diagnosed hypertensive patients
and then start or modify antihypertensive treatment in those with
untreated as well as uncontrolled hypertension (Davis 2001). A
consequence of this study design is that a differential number
of people were receiving antihypertensive drug treatment in the
two arms. At follow-up in year five, 81.2% of patients in the
stepped care arm were taking antihypertensive medication com-
pared to 64.2% of patients in the referred care arm (see details
on included studies). So though it appears that the systematic
follow-up and stepped care approach in HDFP is an important
element in effective clinical care and prompts rigorous antihy-
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pertensive drug treatment, it is not possible to distinguish be-
tween the independent effect of these interventions on blood pres-
sure control. Several other RCTs included both treated and un-
treated hypertensive patients and had differential rates of antihy-
pertensive drug prescribing (Vetter 2000; Midanik 1991; Rudd
2004; Ornstein 2004; Contreras 2005), with rates of prescribing
at higher levels in the intervention arm at follow-up. Secondly,
many RCTs contained multi-faceted interventions that did not
fit into a single intervention category. For example, several RCTs
that were included under categories of patient education, physi-
cian education, health professional led care and organisation of
care also incorporated some form of reminder intervention such
as postal reminders or computer generated feedback (Dickinson
1981;Hamilton 1993;Hawkins 1979;Takala 1979;Takala 1983).
Consequently, it has been difficult to attribute how far single ele-
ments thatmake up complex interventions exert their independent
effect on blood pressure control. In terms of self monitoring, it is
well established that “office” blood pressure readings are around
10/5mmHg higher when compared to ambulatory or self mon-
itored readings (Staessen 1997; Staessen 2004; Williams 2004).
Several of the RCTs did not make any recommendations about
the need for adjustment of target blood pressure readings when
self monitoring was the intervention being assessed, nor did they
appear to anticipate lower blood pressure readings in the self mon-
itoring group (Bailey 1998; Johnson 1978; Pierce 1984; BaquÄö
2005). This may have attenuated the impact of self monitoring
on blood pressure control because of failure to intensify treat-
ment. Poor adherence to therapy is thought to be associated with
poor control of blood pressure (Shea 1992) and medication ad-
herence in hypertension is estimated to be only around 50% to
70% (Ebrahim 1998). Yet only a few trials examined the relation-
ship between adherence to medication and control of blood pres-
sure (Haynes 1976; Johnson 1978; Sackett 1975; Schroeder 2005;
Sookaneknun 2004; de Castro 2006; Wetzels 2007) despite the
significant influence that adherence may have on blood pressure
control. Future studies will need to be designed to assess the rela-
tionship between poor adherence and poor response to antihyper-
tensive drugs in patients with good adherence. Cluster design was
used in 14 of the 71 randomized controlled trials that met the in-
clusion criteria. The majority (8) of these trials correctly adjusted
for clustering effect. However, in those six trials that did not, the
potential exists for unit of analysis errors.However, sensitivity anal-
ysis excluding those studies did not significantly alter our main re-
sults. Lastly, not all RCTs reported on the outcomes of blood pres-
sure achieved or blood pressure control. This has meant that the
relevant a priori outcomes have not been reported for all included
RCTs, and pooling of data from all RCTs has not been possible.
Two further trials were identified which were published outside
the search dates and thus were not included in the analysis. The
first was a 2 × 2 randomized controlled trial with two year follow-
up comparing two self-management interventions for improving
BP control among 636 hypertensive patients in two university-
affiliated primary care clinics (Bosworth 2009). Patients received
usual care, a behavioral intervention (bimonthly tailored nurse-ad-
ministered telephone intervention targeting hypertension-related
behaviours), home BP monitoring three times weekly, or the be-
havioral intervention plus home BPmonitoring. Combined home
BPmonitoring and tailored behavioral telephone intervention im-
proved BP control, systolic BP, and diastolic BP at 24 months rel-
ative to usual care. The success of this combination of self-moni-
toring and nurse-led care appears to consolidate some of the find-
ings of our review. The second was a randomized controlled trial
in 14 community pharmacies in Edmonton, Alberta, Canada, of
227 patients with diabetes who had BPs higher than 130/80 mm
Hg on two consecutive visits two weeks apart (McLean 2008). In
patients who had diabetes and hypertension that were relatively
well controlled, a pharmacist and nurse team based intervention
resulted in a clinically important improvement in BP.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Despite these limitations important messages emerge from this
systematic review. Effective delivery of hypertensive care requires
a systematic approach in the community, incorporating regular
review of patients and a willingness to intensify antihypertensive
drug treatment, usually by adding additional classes of antihy-
pertensive drugs, when blood pressure goals are not being met
(Hypertension 1979; Hypertension 1979a; Hypertension 1986;
Davis 2001). This approach of intensive drug therapy and “tight”
control of blood pressure has been demonstrated to be possible in
clinical trials in hypertensive and diabetic patients alike (Hansson
1999; UK PDS 1998). There are reports of successful systematic
care of hypertensive patients in the community over a 20 year pe-
riod (Hart 1991), but the challenge is to translate these findings
into usual clinical care.
Implications for research
In terms of future studies, careful preliminary work is neededwhen
developing and testing complex interventions and thought needs
to be given as to how their individual and combined effects are
measured (Campbell 2000). Aside from definitive RCTs exam-
ining the effects of self-monitoring and allied health professional
led care (pharmacist and nurses), there is also a paucity of evi-
dence in terms of computer-based clinical decision support systems
(CDSSs) in hypertension and how adherence-enhancing strate-
gies influence subsequent blood pressure control (Ebrahim 1998).
HDFP was a well-funded study with substantial staffing resources.
This meant that the “stepped care” intervention was provided by a
highlymotivated workforce. An economic evaluation of delivering
organised care to hypertensive patients should accompany future
studies. Lastly, none of the included RCTs attempted to manage
8Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
hypertension in the context of overall cardiovascular risk. Future
studies need to be congruent with hypertension guidelines that
recommend treatment and control of blood pressure in combina-
tion with multi-factorial risk reduction (Ramsay 1999).
Conclusions
Effective delivery of hypertension care in the community requires
a rigorous approach in terms of identification, follow-up and
treatment with antihypertensive drugs. This systematic review
shows that such an approach is likely to translate into reductions
in cardiovascular mortality and morbidity (Hypertension 1979;
Hypertension 1979a; Hypertension 1986; Davis 2001). Supple-
mentary and alternative models of care, including self monitor-
ing of blood pressure by patients, blood pressure management by
allied health care professionals and CDSSs require further devel-
opment and evaluation. Educational interventions directed to ei-
ther patients or health professionals alone are unlikely to produce
clinically important reductions in either systolic or diastolic blood
pressure.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ahluwalia 1996
Methods Parallel, individuals, hospital outpatients in a single hospital clinic, USA
Participants Hypertensive (SBP 180mmHg and/or DBP 110mmHg), 95% African American, 49% uninsured, mean
age 56
Interventions (1) Mailed reminder- postcard addressed in the presence of the patient and mailed next day as a reminder
to attend clinic in a week’s time
(2) No reminder card, given routine clinic appointment
Outcomes (1) First follow up visit to walk-in clinic or a continuity medicine clinic- no difference at 6 months (E)
45/53, 85% versus (C) 48/54, 89%
Duration of FU 6 months
Notes No blood pressure data collected at outcome
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Artinian 2001
Methods Pilot RCT
Participants Age >18 years, SBP >140mmHg or >90mmHg or for diabetic patients ?130mmHg or ?85mmHg
Interventions (1) Home BP telemonitoring- self monitoring at home and transmitting BP readings over telephone line
to care providers in order to “facilitate telecounselling and treatment planning”. BP readings transmitted
3 times per week for 12 weeks. (2) Nurse-managed community based BP monitoring. (3) Usual care
Outcomes (1) Blood pressure- mean change SBP 25 mmHg, mean change DBP 14mmHg (E) versus mean change
SBP +1 mmHg, mean change DBP 2mmHg Duration of FU 3 months
Notes Small pilot study with short follow up period
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Bailey 1998
Methods Parallel, individuals based in general practitioner surgeries, Australia
Participants Patients who were about to start BP lowering treatment who did not practice self-measurement, <7%
previously untreated, mean age 53.5 years
Interventions (1) Self monitoring- use of an OMRON HEM706 monitor. Asked to record BP twice daily for 8 weeks
(2) Usual care- no self recording
Outcomes (1) Blood pressure control- significantly worse (E) 148/89mmHg versus (C) 142/89.
(2) Process of medical care-more vigorous in (C) group in terms of increase, addition of medication
(3) Compliance (pill count) (E) 88% versus (C) 94% NS
Duration of FU 8 weeks
Notes 23% patients were not interested in future self-measurement
Outcome assessment: 24 hour ambulatory monitoring
Physicians not instructed to achieve a treatment goal or protocol
Significant disagreement between self monitoring and office measurement found by 19% physicians and
16% patients. In (E) group negative finding most likely due to the fact that physicians were less likely
to alter drug regimen when self-measurement readings were lower than office BP measurement. Finding
most likely to due different responses to process of care
no protocol concerning treatment intensification was provided in this RCT. No adjustment to the lower
self monitor readings were made and no intensification was associated with the intervention
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
BaquÄö 2005
Methods Cluster RCT, Parallel, 180 Primary care basic health care units (BCU) throughout Spain, randomised by
BCU (n=180), analysed by patient (n=1325)
Participants Patients with poorly controlled essential hypertension, defined as systolic blood pressure > or = 140 or
diastolic blood pressure > or = 90 mm Hg
Interventions The patients were given an OMRONHEM-705CP automatic blood pressure monitor on two occasions,
for use during 15 days at weeks 6 and 14. Blood pressure was recorded at each visit (baseline, 6, 8, 14, 16,
and 24 weeks)
Outcomes Control of blood pressure, considered systolic/diastolic blood pressure <140/90 mm Hg (130/85 in
patients with diabetes)
Notes Original in Spanish and only translation of abstract available. Full text in Spanish did not give denominator
for follow-up at 24 weeks so data from follow-up at 16 weeks used
Risk of bias
21Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
BaquÄö 2005 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Barnett 1983
Methods Parallel, individuals based in one community-based health centre in USA
Participants Physicians
nurse-practitioners
(numbers not stated). Patients (n= 115) with sustained hypertension and/or diagnosis of hypertension
and placed on therapy, <2 repeat BP measurements after initial visit. 49% female, mean age 43 years (42%
older than 45 years), 17% black
mean initial BP 150/102mmHg, 7% with history of hypertension, 4% with history of cardiovascular
disease, 15% with family history of hypertension, 34% diagnosed obese
Interventions (1) Computer reminder to GP- automated surveillance system utilizing computer-based medical record
system, generated automatic reminder to GP to check BP of patients. “No attempt was made to monitor
the quality of care as to the degree of BP control”.
(2) Usual care.
Outcomes (1) Evaluate extent BP FU was attempted or achieved, (E) 62/63 (98%) versus (C) 24/52 (46%).
(2) Repeat BP recorded (E) 44/63 (70%) versus (C) 27/52 (52%).
(3) Degree of DBP control achieved (DBP <100mmHg) (E) 44/63 (70%) versus (C) 27/52 (52%)
Duration of FU 24 months.
Notes Intervention improved follow up of patients and in those who were followed up DBP was significantly
improved
Stratified according to age ( 45) and DBP ( 100mmHg)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Billault 1995
Methods Parallel, individuals in a single outpatient clinic, Paris, France
Participants Individuals who attended hypertension clinic, no entry SBP/DBP defined, 88% (C) 83% (E) on BP
lowering drugs. 63% male
Interventions (1) Booklet with personalised standardised medical information explained to patient and their family
doctor. Ten items included on the basis of usefulness of managing hypertension. Patients asked to complete
with family doctor and mail carbon copy to outpatient clinic for entry into computerised record. (2)
Usual care Patients in both groups encouraged to visit family doctor 1-3 times per trimester according to
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Billault 1995 (Continued)
severity of hypertension
Outcomes (1) Process of care in terms of use of services. (2) SBP/DBP- (E) 145.1/88.2mmHg versus (C) 146.2/86.
8; no difference between groups (3) Other cardiovascular risk factors (smoking, exercise, body weight- no
difference between groups. Duration of FU 1 year
Notes 44/82 (54%) of intervention group who were followed up completed personal medical record
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Bloom 1979
Methods Parallel, individuals based after a work-site screening programme US
Participants Patients with elevated blood pressure 140/90mmHg.
Average age 40, white, male 82%, well educated 60% with a masters degree or higher
Interventions (1) Educational material about hypertension, reinforced by a hypertension counsellor one week later,
designed to improve appointment keeping and knowledge
(2) No educational material or counsellor follow up.
Outcomes (1) Number seeking medical care/appointment- significantly improved 15/27 (E- 55.5%), 7/27 (C- 25.
9%)
(2) Knowledge about hypertension- increased in (E) 3.22 versus (C) 2.26
Duration of FU 3 months
Notes RCTconcernedwith initial followupof patients identified as having sustainedhypertension after screening
programme
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Bogden 1998
Methods Parallel, individuals in a single OPD clinic in US
Participants Patients with increased blood pressure, either:
150 or 95mmHg
140 or 90mmHg with CVS risk factors or target organ damage
Mean age 55 sd13, 25% mixed Hawiian ancestory, 57% high school graduates, 87% health insurance
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Bogden 1998 (Continued)
Interventions (1) Pharmacist interacted with physicians and patients:
Patients:
”Go through medication history
“Answered questions
”Encouraged compliance
Physicians:
“Reviewed laboratory data with doctors
”Attached “recommendations” about blood pressure treatment
Control: usual medical care without pharmacist involvement
Outcomes (1) % patients with controlled BP (<140 and <90mmHg)- improved 27/49 (E) 9/46 (C) p<0.001
(2) Mean reduction in SBP/DBP at follow up- improved (E) 132/85mmHg versus (C) 145/92mmHg
p<0.01
(3) Mean medication cost decreased $6.8 (E) increased $6.5 (C)
Duration of FU 16 months
Notes No contamination between doctors
Intervention superior to usual care
Process of care in intervention arm. Pharmacist made 162 recommendations to doctors:
10 new (additional) medication to be started
34 medication dose increase
12 stop medication
5 reduce medication due to side effects
16 renew medication at existing dosage
52 switch to a cheaper drug
20 newer more effective drug
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Brook 1983
Methods Cluster RCT, families unit of randomisation
Participants 2005 Families living in six US cities (47% men, 18% non white, mean age 33.4, range 14-61) Results are
reported for subset of hypertensive subjects, 24.7% (n=294) full health insurance, 24.5% (n=562) partial
health insurance
Interventions (1) Full health insurance- (2) Partial health insurance (three groups at different levels of re-imbusement:
(a) Individual - 95% OPD to ceiling of $150, all inpatient (b) Intermediate- 25-50% both OPD and
inpatient up to $1000 (c) Catastrophic- 95% both OPD and inpatient up to $1000
Outcomes (1) Mean DBP- improved by -1.9mmHg (2) Mean SBP- improved by -1.8mmHg (3) General health (4)
Health habits (5) Risk of dying Duration of FU: 3 years
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Brook 1983 (Continued)
Notes SBP/DBP reported but baseline DBP lower than follow up (see tables 3 and 5 in original report). Subse-
quent report suggested lower SBP/DBP at follow up adjusted for blood pressure at baseline (see table 2
and text). high losses to FUNo details on process of BP care, but free care increased physician contacts and
better lifestyle changes Subgroup analysis: Low-income people with high BP had greater improvement
than high-income--3.5mmHg (low income) versus 1.1mmHg (high-income)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Bulpitt 1976
Methods Parallel, individuals based in 3 hospital hypertension clinics in UK
Participants Intervention directed at hospital physicians (number not stated).
278 patients with diagnosed hypertension referred to clinics. Characteristics of patients: computer group:
56% female, mean age 51years, mean lying BP 178/105mmHg;
control group: 53% female, mean age 48 years, mean lying BP 177/106mmHg
Interventions (1) Computer-held records- allowed doctor to record clinical information in structured format.
(2) Standard hospital notes
Outcomes (1) Content of patient record 15 items- overall better recording in computer group
(2) Length of time of consultation- longer in E (39.9 mins) than C (31.4 mins) at initial consultation,
subsequent consultations no difference.
(3) Patient investigations during RCT- no difference
(4) Drop outs- 25/136 (E- 18%) 36/142 (C- 25%)
(4) Average SBP and DBP- no difference (E) 149/96mmHg (C) 149/97mmHg
Duration of FU 12 months.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Burrelle 1986
Methods Parallel, individuals, hospital outpatients and primary care, USA
Participants 16 treated and non-adherent elderly hypertensive patients, 75% black, 75% women, mean age 69
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Burrelle 1986 (Continued)
Interventions (1) Home visits, education and special dosing devices; addressed psycho-social problems and compliance
problems by means of: medication planners; special dosing devices; individualized instruction on disease
states and treatments- Treatment Information on Medications for the Elderly (TIME)
(2) Usual care
Outcomes (1) Blood pressure control- no difference between groups, (E) 167.8/89.2mmHg versus (C) 165.8/86.
8mmHg
(2) Compliance (Pill counts and direct questioning, taking >80% of medication)- Percent of pills taken:
92% (E) versus 71% (C) (p<0.001)
(3) % with controlled hypertension, no difference, (E) 1/8, 13% versus (C) 1/8, 13%
Duration of FU 8 weeks
Notes Very small and underpowered study
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cakir 2006
Methods Parallel, Outpatient hypertension clinic at a university hospital in Istanbul, Turkey
Participants Persons were eligible if had been diagnosed with hypertension (i.e., mean systolic BP of 140 mmHg and/
or mean diastolic BP, DBP, of 90 mmHg on 3 separate occasions during a 3-week period), and were able
to complete the questionnaire unaided and were aged 18 to 65 years of age. Major exclusion criteria were
currently participating in a structured dietary program aimed at weight reduction, regular participation
in physical activity during the previous 3 months, regular use of drugs that affect dyslipidemia, use of
weight-loss medications, a prior cardiovascular event, or ischemic heart disease
Interventions Patient education (“lifestyle intervention”) while participants in the control group were provided with
routine outpatient services and were asked to maintain their usual lifestyles, including dietary and exercise
habits, for 6 months until they were reexamined
Duration:6 months
Outcomes The primary outcome was SBP. Additional outcomes included DBP, fasting lipids, obesity parameters,
alcohol consumption, smoking, and stress management at 6 months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Carnahan 1975
Methods Parallel
Individuals
Participants V A outpatient clinic US, starting treatment, n=100 (male 98), mean age 54 (E) 57 (C)
Interventions (1) Self Monitoring, Instructed to use own sphygmomanometer twice a day. Readings recorded and
delivered to the clinic when visiting. (2) usual care
Outcomes (1) Mean SBP/DBP- SBP lower at 6 months FU in (E), 7.5mmHg difference
DBP no difference at FU
Duration FU: 6 months
Notes No SDs available, estimated to be 20mmHg SBP, 10mmHg DBP
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Coe 1977
Methods Parallel, individuals based in 2 hospital hypertension clinics in US
Participants Hospital physicians
(number not stated)
116 patients, 90.5% female, mean age 52years, all black
unselected, consecutive referrals to clinics during 6-month period. Characteristics:
(1)Mean of 3 separate pretreatment BP measurements >140/95mmHg
(2)Three return visits while on treatment
(3).BP medication taken as prescribed
Interventions (1) Computer-generated treatment recommendations by algorithm; generated drug type and dose recom-
mendations to physician
(2) Usual physician care
Outcomes (1) Blood pressure- reported in three strata of DBP, <95, 95-105, >105 but no differences between (E)
152.5/99.6mmHg versus (C) 148.7/96.5mmHg
(2) Compliance- self report, no difference
(3) Drugs prescribed- patterns of drug use the same.
Duration of FU months uncertain but weeks of treatment varied within a range of 21 to 40 weeks
Notes Difficult to interpret as trial reported on all outcomes by means of initial DBP strata
Mean SBP/DBP was non significantly better in (C) versus (E).
Overall conclusion computer generated treatment (E) and usual care by physicians (C) was equivalent
Risk of bias
27Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Coe 1977 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Contreras 2005
Methods To study the efficacy of telephone and mail intervention in therapeutic compliance among patients with
mild to moderate hypertension
Design. A prospective controlled multicenter clinical trial with 3 arms
Participants Eighty-five primary care centers in Spain, with a duration of 6 months. Patients. A total of 636 patients
with newly diagnosed or uncontrolled hypertension were included. Interventions. T
Interventions he patientswere randomized anddistributed between the following groups: (i) control (CG) - under routine
clinical management; (ii) mail intervention (MIG) - received a mailed message reinforcing compliance
and reminding of the visits (15 days, 2 and 4 months),- (iii) telephone intervention (TIG) - received a
telephone call at 15 days, then at 7 and 15 weeks
Outcomes Five hundred and thirty-eight patients completed the study (261 males); 85.5% were compliers (CI=82.
5-88.5, n=460). The MPC was 95.1 +/- 19.6% (CI=93.28-96.92). The CG consisted of 182 individuals,
MIG=172 and TIG=184. Compliers represented 69.2% of the CG (CI 62.5-75.9%), 91.3% (CI=87.1-
95.5) of the MIG (p=0.0001) and 96.2% of the TIG (CI 93.5-98.9%); the final MPC was 89.6% +/-
15 in CG, 96.6% +/- 12 in MIG and 99.1 +/- 26.8 in TIG (p=0.0001). The percentage of controlled
subjects was 47.2% in CG (CI=40-54.4), 61.3% in MIG (CI=54.1-68.5%) and 63.3% in TIG (CI=56.
4-70.2%) (p<0.05). Conclusions. TIG and MIG are effective measures for improving patient compliance
in hypertension
Notes This is a three arm study of a mail intervention, a telephone intervention and a usual care group
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Cummings 1985
Methods Hypertensive patients attending in a single urban family practice
Participants Patients, aged 19 to 96, mean age 60. 62% female, 91% black, 11% newly diagnosed, 75% SBP
<140mmHg and DBP >90mmHg
Interventions (1) Appointment reminder- reminder card sent one week in advance of appointment and telephone
patients who missed appointments to schedule new ones (2) Usual care
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Cummings 1985 (Continued)
Outcomes (1) Appointment keeping rate-appointments improved in (E- 87%) versus (C- 79%). (2) Dropouts from
treatment- drop outs less at 4 months in experimental group (E- 87/486, 18%) versus (C- 150/487, 31%)
(3) Blood pressure control- average SBP/DBP improved in experimental group(SBP-2mmHg, p=0.18
and DBP -1mmHg, p=0.75) (4) Proportion of patients with controlled hypertension (<140/90)- 31%
(E) versus 25% (C) Duration FU 8 months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
de Castro 2006
Methods double-blind randomized clinical trial,
Setting. Single hospital clinic outpatient in brazil
Participants A total of 71 patients in a single hospital clinic outpatient in brazil
Included: >18 years,with uncontrolled hypertensive,
Interventions (i) control (CG) - under routine clinical management and sham intervention
(ii) intervention (IG) - received a Pharmaceutical care programme delivered by 9 trained pharmacists:
Patient education and support
Outcomes ABPM after 6 months (large cuff was used in >32cm arms)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Dickinson 1981
Methods Factorial, Cluster, RCT
Participants Four clinical teams in Family Medicine Centre in USA, 4 faculty physicians 37 residents. Each team
received on of the interventions. 250 Patients, 69.9% female, mean age 49.6 years, 70.4% white mean
weight 78.9kg, mean baseline BP 159/89mmHg. Inclusion criteria: (1) Hypertensive patients visiting
practice during 4-month baseline period (2) Elevated systolic or diastolic pressure at last baseline visit (3)
At least one visit during 7-month intervention period
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Dickinson 1981 (Continued)
Interventions (1) Computer-generated feedback-monthly feedback reports on individual patients for physician, con-
taining identification, age, date of last visit and latest BP in those with uncontrolled hypertension (age
18-44 >/=140/90; 45-64 >/=150/95; age >64 >/=160/95) or overdue appointments
(2) Education programme- designed to increase physician awareness about non-compliance, plan long
termmanagement based on periodic assessment, encourage family, behavioural and drug therapies. Three
separate self instructions
(3) Both
(4) Neither
Outcomes 1) Follow up appointments increased in interventions-feedback 3.4, education 3.3, both 3.2, control 2.
6 NS. (2) Knowledge-significantly improved in physicians who received education only, feedback 76,
education 84, both 78, control 74 (3) Blood pressure control- no difference - feedback 145/86mmHg,
education 149/85mmHg, both 149/84mmHg, control 148/83 (4) % with controlled hypertension- non
significant differences, feedback 65%, education 63%, both 57%, control 58% Duration of FU 7months
Notes Intervention randomised by, directed at physicians, analysis by patient No account taken of clustering.
Explains uneven patient numbers per arm of RCT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Earp 1982
Methods Parallel Individuals
Participants Hypertension, taking BP medication that had been initiated, altered or re-started. Based in outpatient
hypertension clinic or family practice clinic
n=218, mean age 48, 59% female, 77% black
Interventions (1) Home visits- over 18 months by nurse or pharmacist. Provided a “test of how effectively home-visiting
health practitioners could motivate and/or reinforce positive health behaviours, including medication
compliance” (2) Home visits plus involvement of “significant other”- involved daily/several times a week
BP monitoring (3) Usual care
Outcomes (1) Home visit group versus usual care: proportion of patients in each group with uncontrolled hyperten-
sion (DBP >/=95mmHg)- significant effect at year 2 (E) 21% versus (C) 42%, not significant at year 1
(E) 34% versus (C) 34%
(2) Home visit and involvement of significant other versus usual care; proportion of patients in each group
with uncontrolled hypertension (DBP 95mmHg)- non significant effect at year 2 (E) 25% versus (C)
42%, not significant at year 1 (E) 39% versus (C) 34%
Duration of FU: 1 year
Notes Large proportions lost to follow up at year 2, hence follow up at 1 year when pooling data.
Mean number of BP medication taken declined in the two intervention group (1.7 to 1.5 Group 1 and
1.5 to 1.4 Group 2) but increased in control group (Group 3 1.6 to 1.8); between group differences non
30Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Earp 1982 (Continued)
significant
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Evans 1986
Methods Cluster- physicians stratified to solo or group practice and randomly allocated within strata
Participants Canadian family physicians. Eligible patients, age 30 to 69 years, either DBP >90mmHg at one home
visit and taking BP medication or no BP medication and DBP >90mmHg on 3 times at home visits
Interventions (1) Mailed CME to physicians 14 weekly instalments of information, chart and fu appointment system
to encourage detection and recall of patients (2) Usual care
Outcomes (1) Blood pressure- (DBP<90mmHg, (E) 67% versus (C) 67%, non significant. (2) # visits for BP check-
no difference (3) # patients told BP elevated- no difference (4) # patients on BP medication- no difference
(5) Mean % compliance rate- no difference (6) % patients with controlled blood pressure- no difference
Duration FU 1 year
Notes Cluster RCT- BP data aggregated at cluster level.
Nodifference foundbetween intervention andusual care, 76%(E) and79% (C) patients onBPmedication
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Fielding 1994
Methods Parallel, individuals at four work sites in the US
Participants Patients with increased blood pressure, either:
SBP 140 and/or DBP 90mmHg identified during work-site screening. 16%female, 30.5% taking BP
lowering durgs
Interventions (1) IMPACT consisted of monthly 10 minute individual sessions for patients with counsellor at work site
that included:
“Assessment of current behaviours
”Discussion re: treatment goals
“Compliance
”Mailed monthly package including personalised blood pressure information
“Incentives offered e.g. coupons for free sports equipment
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Fielding 1994 (Continued)
”Sites were requested to offer at least six classes or demonstrations related to BP control during the year
(2) Usual care
Outcomes (1) Mean SBP/DBP changes-
SBP: significantly improved 138.1mmHg (E) versus 144.5mmHg (C)
DBP: -no difference 86mmHg (E) versus 86.5mmHg (C)
Adjusted difference:
SBP 7.6mmHg, p<0.05
DBP 2.4mmHg, NS
Duration of FU 1 year
Notes Statistically significant change for SBP (but not DBP) after adjustment for age, sex and baseline blood
pressure
A significantly higher proportion of intervention group started BP lowering drugs (E) 13/49, 26.5% (C)
5/52, 9.6%
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Fletcher 1975
Methods Parallel, individuals based in single emergency room in US
Participants Patients who attended emergency department with DBP 100mmHg and who had been given a follow up
appointment for a medical clinic
Interventions (1) Reminder (letter or phone) to attend follow up appointment at clinic, offer of assistance if problems
arose, followed up until attended clinic or missed two consecutive appointments
(2) Usual care
Outcomes (1) Returned to initial medical clinic appointment significantly improved 62/74 (E- 84%), 44/70 (C-
63%).
(2) Blood pressure control the same at FU 38/74 (E- 51%), 37/70 (C- 53%)
Duration of FU 5 months
Notes Improved initial attendance but blood pressure control in both groups the same. Process of care the more
vigorous in (E) group but (E- 38%), (C- 33%) said that they were on BP lowering drugs.
Blood pressure control defined in age-specific categories
20-39 <140/90
40-59 <150/95
>60 <160/100
Risk of bias
Item Authors’ judgement Description
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Fletcher 1975 (Continued)
Allocation concealment? Unclear B - Unclear
Friedman 1996
Methods Parallel, individuals from 29 different communities, Boston, USA
Participants Under care of physician for hypertension onBP lowering drugs, SBP >/=160mmHgorDBP>/= 90mmHg
on average two readings. 90% white, 77% female, mean age 76 years
Interventions (1) Home monitoring and telecommunication system
“Weekly automated home blood pressure recording.
”Telephone-linked computer system (TLC)- computer-based telecommunications system that converses
with patients in their homes, patients contacted weekly. Provides advice concerning their blood pressure,
understanding of BP lowering medication, adherence to medication, symptoms that might relate to side
effects of therapy. Information directed to patient’s physician
(2) Usual care
Outcomes (1) Adherence to medication- improved by 18% (E) vs 12% (C), p=0.03.
(2) Mean change in SBP/DBP- no difference for SBP, (E) 158.5mmHg versus (C) 156.4mmHg, p=0.2;
significant difference for DBP, (E) 80.9mmHg versus (C) 83.2mmHg, p=0.02;
(3) Cost effectiveness- most cost effective for non-adherent patients
Duration of FU 6 months.
Notes Cost effectiveness measured all computer and telecommunication costs, facilities charges, supplies and
support personnel for start-up and maintenance of the system. Cost effectiveness ratios were computed
for medication adherence improvement and DBP decrease using regression analysis
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Garcia-Pena 2001
Methods Parallel, individuals, elderly ( 60) age-stratified sample recruited from 12 family medical centres, Mexico
city, Mexico
Participants Hypertension, mean SBP 160 or/both DBP 90 in untreated patients or treated hypertension patients
Mean BP level 161.9/90.8 (C) 162.1/90.9 (E) average age 70.6 years
Interventions (1) Nurse-based intervention
Nurses trained in aging and clinical aspects of hypertension including:
”Personal interviews
“Health behaviour change models
”Process of negotiation
“Ethical aspects of home visits
33Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Garcia-Pena 2001 (Continued)
On each visit nurse did the following:
”Measured BP
“Discussed baseline health check and discussed lifestyle changes
”Guided patients in healthier lifestyle and negotiated specific targets
“Revised pharmacological treatment
”Adherence encouraged
Frequency of visits 2-4 weeks
(2) Usual care from institute’s clinic and mailed pamphlet about hypertension
Outcomes (1) Blood pressure- mean change SBP 3.31 mmHg p=0.03, mean change DBP 3.67mmHg p<0.001
(2) Weight -1.1 kg significantly reduced
(3) Sodium excretion -5.8 ns
(4) Control BP <160/90mmHg improved 36.5% (E) versus 6.8% (C)
(5) Exercise- slow walking exercise increased (E) 9.1% versus decreased (C) 0.7%
(6) Not taking antihypertensive drugs (E) 15.9% versus (C) 26.9%
(7) Antihypertensive drug usage- increased in (E) change from baseline12.5% versus (C) 5.3%, difference
7.2% p=0.02
Duration of FU 6 months
Notes Well conducted RCT. Nurse intervention aimed at both pharmacological and non-pharmacological man-
agement of hypertension. Had positive effect on mean SBP/DBP and BP control with increases in number
taking antihypertensive medications. Non pharmacological treatment also effective at reducing weight,
increasing exercise with non significant reduction in sodium excretion
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Gullion 1987
Methods Factorial RCT, randomised by physician (n=111), analysed by patient (n=2583), San Francisco USA.
Average of 23 patients per practice
Participants Hypertensive patients using anti-hypertensive medication, had a DBP >90mmHg at some stage of their
care. Age range 20-80 years
Interventions (1) Medical education-
“Individualised feedback on medical record information, detailed peer-review
”Syllabus material
“Educational sessionbymeans of telephone call with faculty expert discussing feedback reports and syllabus
materials.
(2) Behavioural education-
”Individualised feedback on patient survey summaries, detailed peer-review
“Syllabus material
”Educational session, telephone call with faculty expert discussing feedback reports and syllabus materials
(3) Both interventions
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Gullion 1987 (Continued)
(4) Neither intervention
Outcomes (1) DBP- no difference between four groups either for mean DBP (85.17, 85.59, 85.16, 85.79 mmHg
respectively) or for % with controlled DBP (68.65%, 66.78%, 67.93%, 68.25% respectively) at follow
up.
(2) Lifestyle outcomes- no difference apart from decreased BMI in behavioural group.
(3) Health promotion advice given- more likely to be given advice re: medication regimen, side effects of
drugs, sodium intake in behavioural group
Duration of FU 1 year
Notes Negative RCT with regard to primary outcome of DBP.
Caution required with interpretation of lifestyle and health promotion outcomes. Multiple comparisons
DBP reported but not usable because no baseline numbers randomised reported or standard deviations
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Halme 2005
Methods Multicenter, randomized, parallel-group study in 55 primary care health centres in Finland
Participants 269 patients randomised and 232 analysed: (119 C and 113 E). Persons were eligible if had been diagnosed
with hypertension (i.e., meanBP of 140/90 or higher measured twice each time at 4 consecutive occasions)
, consent, aged between 20-75 years of age,and were excluded with obesity, secondary or malignant
hypertension, A fib or flutter
Interventions Intermittent self-monitoring of BP. Home BP was measured in the self-monitoring (SM) group at 0, 2,
4, and 6 months, and in the control (C) group at 0 and 6 months.
Outcomes SBP, DBP and % controlled,
Duration:6 months
Notes “Home” results only used in analysis as by definition self-monitoring takes place outside office
Risk of bias
Item Authors’ judgement Description
Allocation concealment? No B - Unclear
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Hamilton 1993
Methods Parallel, individuals based in hypertension clinic in tertiary care teaching medical centre, US
Participants Thirty four treated hypertensives DBP 90mmHg and/or SBP 160 mmHg, participating in therapeutic
hypertension regimen. Mean age 54 years, white, married, high school educated
Interventions (1) Postcard reminder one week before the next regularly scheduled appointment, a 30 to 40 min inter-
vention with the nurse practitioner before the appointment with the physician (including tailored care
plan, information on hypertension, discussion of risk factors, max. 45 min total time), follow up phone
call one month after the intervention to evaluate the negotiated plan of care.
(2) Usual care- no self recording
Outcomes (1) SBP/DBP- improved SBP difference -17.3 mmHg, not DBP -4.7 mmHg, (p=0.03 and 0.22 respec-
tively)
(2) Compliance (self report)- no difference, adherence score of 27.5 in intervention group vs 24.5 in
control group (p=0.12)
(3) Mean number of appointments kept- improved 97% (E) v 74% (C) (p=0.04)
(4) Physician rated patient adherence- improved (E), adherence score of 29.18in intervention group vs
23.92 in control group (p=0.005)
Duration of FU 6 months
Notes SBP improved, mean number of appointments kept improved in (E) group, adherence no difference on
self-report
Small RCT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hawkins 1979
Methods Parallel
Individuals
Participants Medical OPD clinic, San Antonio, US, patients fu for hypertension (42% E) (49% C) and diabetes or
both (28% E) (21% C), mean age 61 (E) 60 (C), >90% Mexican Americans, (female 76% E, 78% C)
Interventions (1) Clinical pharmacist- chronic disease management in OPD setting (medical care monitored by family
practice faculty)
(2) Usual care by physician
Outcomes (1) Kept-clinic appointments
(2) Compliance with medication (prescription record)- improved diuretic only: 60.5% adherent (E) vs
52.9% (C) (p<0.7), diuretic plus methyldopa: 84.6 % (E) vs 65.4% (C) (p=0.2)
(3) Kept OPD appointments- 83.3% (E) vs 73.8% (C) (p<0.0005)
(4) Frequency of clinic visit- 6.69 (E) vs 5.38 (C) (p=<0.001)
(4) Mean SBP (E) 147mmHg versus 141 (C); p<0.01. Mean DBP 84mHg (E) versus 84mHg (C) non
significant
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Hawkins 1979 (Continued)
Duration FU 24-29 months
Notes Improved for pharmacist led care(E) for:
(1) Kept OPD appointments
(2) Frequency of OPD appointments
(3) Mean SBP between group comparison- improved in (E) group but worse for DBP
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Haynes 1976
Methods Parallel
Individuals
Participants Hypertensive males (n=39), not compliant (pill counts <80%) or at goal DBP ( 90mmHg) after 6 months
(previously enrolled in a separate RCT, see Sackett 1975)
Interventions (1) Patient self monitoring and education, includes:
“Home self-measurement of BP
”Home BP and medication charting
“Tailoring- patients interviewed to improved medication taking
”Increased supervision and reinforcement- fortnightly review including positive re-enforcement.
All interventions supervised and executed by non health professional programme coordinator
(2) Usual care
Outcomes (1) Compliance- increased in experimental group (E) 65.8 versus (C) 43.2, p=0.025
(2) Control of DBP- increased in experimental group, (E) 93.1mmHg versus (C) 96.4mmHg, p=0.12
(3) Combined compliance and DBP targets- increased in experimental group
Duration of FU 1 year.
Notes (1) No data given- change in DBP and compliance reported
(2) Experimental group patients received significantly more attention than control patients (5 hours over
6 months)
(3) Physicians treating experimental patients prescribed more vigorously
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
37Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hennessy 2006
Methods Cluster factorial randomized trial.
SETTING: Academic health system using an ambulatory electronic medical record
Participants A total of 10,696 patients with a diagnosis of hypertension cared for by 93 primary care providers.
Randomised by provider (n=93), analysed by patient (n=7159)
Interventions Academic detailing, provision of provider-specific data about hypertension control, provision of educa-
tional materials to the provider, and provision of educational and motivational materials to patients
Outcomes The primary outcome was blood pressure control, defined as a blood pressure measurement below 140/
90 mm Hg, and was ascertained from electronic medical records over 6 months of follow-up
Notes This trial is factorial involving education of provider and patient. absolute data only for BP and control
data entered
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hetlevik 1998
Methods Cluster (29 health centres, 53 family practitioners), analysed by patient (2239 patients). Two regions in
Norway
Participants Hypertensive patients (baseline BP level given), mean age 64 years, 57% female
Interventions (1) Computer based decision support system (CDSS). Doctors and assistants trained and received a user
manual. Re-enforcement by means of telephone repetitions seminar on risk intervention and further
demonstration of CDSS.
(2) Usual care
Outcomes (1) SBP/DBP- SBP no difference (E) 156.8mmHg versus (C) 155.6mmHg NS, DBP (E) 88.8mmHg
versus 89.8mmHg, p<0.05 (2) Cholesterol (3) % smokers (4) BMI (5) Coronary heart disease risk score.
All other outcomes no different between groups (6) Recording of risk factor data- improved slightly in
(E) group for cholesterol and family history. Duration of FU 24 months
Notes Only 104 (11%) patients had CDSS used on them during trial period
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Hetlevik 1999
Methods Cluster (29 health centres, 53 family practitioners), analysed by patient (2239 patients). Two regions in
Norway
Participants Hypertensive patients (baseline BP level given), mean age 64 years, 57% female
Interventions (1) Computer based decision support system (CDSS). Doctors and assistants trained and received a user
manuel. Re-enforcement by means of telephone repetitions seminar on risk intervention and further
demonstration of CDSS. (2) Usual care
Outcomes (1) SBP/DBP- SBP (E) 156.8mmHg versus (C) 155.6mmHg NS, DBP (E) 88.8mmHg versus 89.
8mmHg, p<0.05
(2) Cholesterol
(3) % smokers
(4) BMI
(5) Coronary heart disease risk score.
All other outcomes no different between groups
(6) Recording of risk factor data- improved slightly in (E) group for cholesterol and family history
Duration of FU 24 months.
Notes Only 104 (11%) patients had CDSS used on them during trial period.
No account for clustering reported in the analysis section
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Hunt 2004
Methods Primary care practice-based research network in which 9 clinics located in Portland, Oregon
Participants Patients with mildly uncontrolled hypertension as defined as a last blood pressure of 140 to 159/90 to 99
mmHg from query of an electronic medical record database
5473 total randomised and 312 analysed (E 162 and C 150)
Interventions Patients randomized to intervention were mailed 2 educational packets approximately 3 months apart.
The first mailer included a letter from each patient’s primary care provider. The mailer included a booklet
providing an overview of hypertension and lifestyle modification and a refrigerator magnet noting target
blood pressure. The secondmailing also included a letter from the patient’s primary care provider, a second
educational booklet focused on medication compliance and home blood pressure monitoring, and a blood
pressure logbook. The control group consisted of similar patients receiving usual care for hypertension
Outcomes The primary outcome was blood pressure control, defined as a blood pressure measurement below 140/
90 mm Hg, and was ascertained from electronic medical records over 6 months of follow-up. Also SBP
and DBP as secondary outcomes
Patients from each group were randomly selected for invitation to participate in a study visit to measure
blood pressure and complete a survey (intervention n= 162; control n= 150). No significant difference
was found in mean blood pressure between intervention and control patients (135/77 mmHg vs 137/77
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Hunt 2004 (Continued)
mmHg; P=.229). Patients in the intervention arm scored higher on a hypertension knowledge quiz (7.
48 +/- 1.6 vs 7.06 +/- 1.6; P=.019), and reported higher satisfaction with several aspects of their care. No
significant difference was seen in the prevalence of home blood pressure monitoring ownership or use
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Hypertension 1979
Methods Patients identified at 14 ”HDFP centres throughout the US (13 by residential area- census tract, proba-
bility sample of larger areas, entire housing projects or in one centre by employment roll of industries).
Randomisation at the patient level after initial screening. Initially screened for DBP, 2 stage process: (1)
All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for second
screen at clinic, regardless of whether taking BP lowering drugs or not. (2) If mean DBP 90mmHg,
patient eligible and randomised. 10,940 agreed to randomisation Randomisation stratified according to
entry DBP and HDFP centre: (1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%) (2) Stratum ii- 105-
114 mmHg, n=2,052 (18.8%) (3) Stratum iii- 115 mmHg, n=1,063 (9.7%) No SBP entry criteria and
no upper limits of BP 11,386 persons randomised but 446 subsequently excluded due to randomisation
error that occurred at one clinic
Participants Inclusion criteria: (1) Men and women age 30 to 69 years (2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg Exclusion criteria: (1) Terminally ill (2) Institutionalised 10,
940 randomised, 54% male, 45% black Antihypertensive drugs taken at start of RCT: SC (26.3%), RC
(25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment bymeans
of:
“Free care- visits, drugs, investigations, transport
”Emphasis placed on clinic attendance and compliance- pill counts used
“Convenience- low waiting times, parmedical personnel, physician on call
”Stepped drug treatment according to BP response
“Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every
2 months
(2) Referred care (RC): referred to their ”primary sources of care, usually own physicians
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BP
measurement and at the clinic at years 2 and 5 for an examination. At each contact each RC participant
was advised to visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special
steps were taken to achieve contact with a physician
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
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Hypertension 1979 (Continued)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step
2, 9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihyper-
tensive therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Hypertension 1979a
Methods Patients identified at 14 ”HDFP centres throughout the US (13 by residential area- census tract, proba-
bility sample of larger areas, entire housing projects or in one centre by employment roll of industries).
Randomisation at the patient level after initial screening. Initially screened for DBP, 2 stage process:
(1) All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for
second screen at clinic, regardless of whether taking BP lowering drugs or not.
(2) If mean DBP 90mmHg, patient eligible and randomised. 10,940 agreed to randomisation Randomi-
sation stratified according to entry DBP and HDFP centre:
(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)
(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)
(3) Stratum iii- 115 mmHg, n=1,063 (9.7%)
No SBP entry criteria and no upper limits of BP
11,386 persons randomised but 446 subsequently excluded due to randomisation error that occurred at
one clinic
Participants Inclusion criteria:
(1) Men and women age 30 to 69 years
(2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg
Exclusion criteria:
(1) Terminally ill
(2) Institutionalised
10,940 randomised, 54% male, 45% black
Antihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
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Hypertension 1979a (Continued)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment bymeans
of:
“Free care- visits, drugs, investigations, transport
”Emphasis placed on clinic attendance and compliance- pill counts used
“Convenience- low waiting times, parmedical personnel, physician on call
”Stepped drug treatment according to BP response
“Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every
2 months
(2) Referred care (RC): referred to their ”primary sources of care, usually own physicians
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BP
measurement and at the clinic at years 2 and 5 for an examination. At each contact each RC participant
was advised to visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special
steps were taken to achieve contact with a physician
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step
2, 9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihyper-
tensive therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Hypertension 1982
Methods Patients identified at 14 ”HDFP centres throughout the US (13 by residential area- census tract, proba-
bility sample of larger areas, entire housing projects or in one centre by employment roll of industries).
Randomisation at the patient level after initial screening. Initially screened for DBP, 2 stage process:
(1) All 158,096 screened (89% of all age-eligible patients), if average DBP was 95mmHg invited for
second screen at clinic, regardless of whether taking BP lowering drugs or not.
(2) If mean DBP 90mmHg, patient eligible and randomised. 10,940 agreed to randomisation Randomi-
sation stratified according to entry DBP and HDFP centre:
(1) Stratum i- 90-104 mmHg, n= 7,825 (71.5%)
(2) Stratum ii- 105-114 mmHg, n=2,052 (18.8%)
(3) Stratum iii- 115 mmHg, n=1,063 (9.7%)
No SBP entry criteria and no upper limits of BP
11,386 persons randomised but 446 subsequently excluded due to randomisation error that occurred at
one clinic
Participants Inclusion criteria:
(1) Men and women age 30 to 69 years
(2) Average home screening DBP 95mmHg
(3) Confirmed follow up DBP 90mmHg
Exclusion criteria:
(1) Terminally ill
(2) Institutionalised
10,940 randomised, 54% male, 45% black
Antihypertensive drugs taken at start of RCT: SC (26.3%), RC (25.7%)
Interventions (1) Stepped care (SC), designed to provide rigorous, systematic, antihypertensive drug treatment bymeans
of:
“Free care- visits, drugs, investigations, transport
”Emphasis placed on clinic attendance and compliance- pill counts used
“Convenience- low waiting times, parmedical personnel, physician on call
”Stepped drug treatment according to BP response
“Patients seen at intervals determined by their clinical status, at least every 4 months, and generally every
2 months
(2) Referred care (RC): referred to their ”primary sources of care, usually own physicians
All SC (E) and RC (C) participants seen at home at years 1, 2, 4 and 5 for health history and BP
measurement and at the clinic at years 2 and 5 for an examination. At each contact each RC participant
was advised to visit a physician. If severe hypertension (DBP 115mmHg or end organ damage) special
steps were taken to achieve contact with a physician
Outcomes (1) # (%) on antihypertensive medication- higher for SC 81.2%, compared to RC 64.2% by year 5.
(2) SBP/DBP level- lower for SC (130/84mmHg) vs RC (140/89) at 5 year FU
(3) % controlled blood pressure (HDFP goal)- improved SC versus RC.
(4) All cause mortality- significantly better 350/5485 (6.38%) vs 421/5455 (7.78%)
All outcomes apply across 3 strata of entry DBP. Most of BP reduction occurred by end of year 1
Duration FU 1 and 5 years (mortality)
Notes Data reported in 3 strata of entry DBP
At one year 84.4% (SC) versus 59.1% (RC) taking antihypertensive medication
Step 1- 32.7% v 12.1%
Step 2- 23.6% v 16%
Step 3- 3.3% v 2.3%
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Hypertension 1982 (Continued)
Step 4- 2% v 2%
Total drug status known at 1 year, 82.4% SC v 82.8% RC
Intensity of BP medication in SC at 5 years: 42% taking single drug- step 1, 27% taking two drugs- step
2, 9% taking 3 drugs- step 3, 11% taking 4 or more drugs, step 4and 5 at 5 years
HDFP defined goal DBP as 90mmHg for those entering with DBP 100mmHg or receiving antihyper-
tensive therapy and a 10mmHg decrease for those entering with DBP of 90-99mmHg
Mortality FU 5 years, mean BP data reported at 1 year and 5 years
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Jewell 1988
Methods Hypertensive patients in a single practice in the UK
Participants Patients aged 30-64 years.
Newly diagnosed: raised DBP >100mmHg aged 30-39, >105mmHg aged >40
Previously diagnosed: DBP >95mmHg on 3 measurements at a single visit
Interventions (1) Nurse-led clinic. Agreed protocol determined treatment and frequency of attendance in both groups.
Target was to reduce DBP <90mmHg, 15 minute consultation.
Note: both nurse led and doctor led care was by means of identical protocol.
(2) Usual care-general practitioner 10 minute consultation
Outcomes (1) Mean SBP/DBP- between group difference in mean SBP -0.8mmHg (-8.7 to 24.7) NS, DBP - 0.
4mmHg (-6.2 to 7) NS.
(2) Proportion with DBP <90mmHg
10/15 (E- 67%)
12/19 (C- 63%)
(3) Quality of data recording (better in nurse group for pulse, weight, urine testing)
(4) Frequency of attendance (no difference, mean annual rates 5.7 (C)
6 (E) groups.
(5) Knowledge of medication (no difference)
(6) Reactions to the service (no difference)
Duration FU 1 year
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Johnson 1978
Methods Factorial RCT,
randomised at individual level, stratified by age and sex.
Participants Screenees from a Canadian shopping centre, n=140 (male 82), age 35-65 years
All taking BP lowering medication for 1 year with uncontrolled hypertension (DBP 95mmHg)
Interventions (1) Self recording- given BP recording device, take BP daily and take charts with BP records to their
physician
(2) Home visits- BP measured in their homes every 4 weeks with result given to them and physician.
Both groups visited at home after 2 weeks
(3) Both interventions
(4) Neither intervention
Outcomes (1) Changes in mean DBP- no difference
(2) Changes in mean compliance- no difference.
(3) Changes mean compliance in those with initial compliance <80%- no difference
(4) Change mean DBP in those with initial problems remembering to take BP medication- subgroup
effect in initially difficult to remember group
(5) Change in strength in therapy- no difference
Duration of FU 6 months
Notes More “explanatory” RCT, follow on from Haynes. In contrast to positive findings in Haynes RCT, this
RCT proved to be negative. Main difference in this RCT is that home visitors dealt with onlymeasurement
of BP, no attempts made to influence medication taking. No standardised treatment regimen or goal BP
advocated to treating physicians
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Krieger 1999
Methods Parallel, individuals in a single “low income” area of Seattle, USA
Participants Hypertensive patients (entry SBP 140mmHg or DBP 90mmHg). 4761 had BP measured, 759 (15.9%)
eligible, 421 (55.5%) participated. Overall, 40% taking BP lowering medication, 79% black, 66% below
federal poverty level, 33% BP 160/100mmHg. All participants paid $25 for completing study
Interventions (1) Outreach and tracking by community health worker. Provided: referral to medical care and assistance
with finding a provider; ensure appointment with health worker; appointment reminder letter; follow
up patient (up to 3 times) to see if appointment kept; new appointment if one missed (up to 3 times);
assistance to reduce barriers to care including transport, child care or other services
(2) Usual care
Outcomes (1) Follow up appointment within 90 days- (E) 95/146 (65.1%) versus (C) 77/165 (46.7%).
(2) SBP/DBP-improved SBP (E) 139.4mmHg versus (C) 141mmHg, DBP no difference (E) 84.6mmHg
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Krieger 1999 (Continued)
versus (C) 84.3mmHg
Duration of FU 3 months.
Notes Study designed to assess follow up within 30 days. Large differential loss to follow up (greater in inter-
vention arm).
Mean SBP/DBP data provided by authors of study
No intention to treat analysis.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Levine 1979
Methods Factorial trial with 8 groups of various combinations of the 3 interventions and control individuals at two
hypertension clinics in US
Participants 91% black, median age 54 years, 70% female, low income ($45250 median yearly income).
BP (mmHg) entry criteria based on age:
20-39: >140/90
40-59: >150/95
60: 160/100
Interventions (1) Three interventions:
“Exit interview- individualised 5-10 minute counselling session, explaining and re-inforcing instructions
to the patient
”Instructional session with adult at home concerning adherence and follow up care
“Group sessions- three, one hour sessions led by social worker
”Seven experimental groups and one control group
(2) Usual care with none of above interventions
Outcomes (1) Deviation in weight from ideal weight- significantly better in patients who received all 3 interventions
compared to those who received none
(2) Appointment keeping (ratio of kept/scheduled)- improved in group who received all 3 interventions
versus control at 2 yrs (E) .68 versus (C) .63; no difference at 5 yrs (E) .95 versus (C) .83
(3) Adherence to drug therapy- all improved, greatest in 3 intervention arm versus control (53% vs 40%)
(4) % patients with controlled BP - increased at 2 years (E) 52% versus (C) 42%; 5 years (E) 66% versus
(C) 56%. Significantly better in four intervention groups compared to control at 5 years
(5) All cause mortality- cumulative mortality better in all experimental groups combined (12.9) compared
to control group (30.2)
(6)Cost effectiveness-multiple interventions appearmore effective, not necessarilymore cost effective. Au-
thors feel that may be better to use single interventions depending on setting and financial constraints{821}
Duration of FU 2 and 5 years.
Notes Multiple comparisons in results section: 7 intervention arms and one control group
In addition no a priori sub-group analysis
Blood pressure control age-specific categories
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Levine 1979 (Continued)
<40 <140/90,
40-59 <150/95
60, <160/100
Substantially greater numbers lost to follow up in (C) arm at 2 and 5 years
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Logan 1979
Methods Parallel
Individuals
Participants Volunteers from business settings with newly diagnosed hypertension (DBP 95mmHg, or DBP 91-
94mmHg and SBP >140mmHg)
Interventions (1) Work-site care- nurse management according to a standard protocol- including drug regimen and
regular review, once monthly if BP not controlled
(2) Usual care from their own family physicians
Outcomes (1) # patients taking BP treatment- increased in Experimental group (177/206, 86% vs 108/204, 53%)
(2) Mean DBP- improved in (E) 94.3mmHg versus (C) 90.3mmHg, p<0.01.
(3) Reach goal DBP- 50% (E) versus 28.9% (C).
(4) Compliance-better in experimental group (67.6% vs 49.1%)
Duration of FU 6 months
Notes Goal DBP <90mmHg if entry DBP >95mmHg; or <6mmHg in those with entry DBP 95mmHg or less
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Marquez 2004
Methods Comparative, controlled, multicenter, randomized cluster study
Participants SETTING: 26 primary care health centers in Spain. PARTICIPANTS: 26 researchers were randomized
to a control group or an intervention group (52 patients each, for a total of 104 patients). All patients
were receiving monotherapy for uncontrolled hypertension
104 total eligible patients 52 IG and 52 CG
Analyzed 33 CG and 34 IG
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Marquez 2004 (Continued)
Interventions Patients in the control group received their physician’s usual interventions. Patients in the intervention
group received messages and reminders sent to their mobile phones 2 days per week during 4 months
Outcomes Tablets were counted and blood pressure wasmeasured at the start of the study and 1, 3, and 6months later.
The percentage of compliers, mean percentage of compliance and degree of control of hypertension were
compared. The reduction in absolute and relative risk was calculated, as was the number of individuals
needed to treat to avoid noncompliance
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Martinez-Amenos 1990
Methods Parallel
Individuals
Participants Hypertension Registry from 19 primary care centres in Spain. Mean age 61 years, 59% female
Initial volunteers asked if they wished to participate; those agreeing were randomised and labelled “moti-
vated” group; group who declined to participate also followed up “non motivated”
Interventions (1) Individual education- comments and explanations to errors encountered in answers to baseline knowl-
edge questionnaire
(2) Team education- 2 talks given by nurses or doctors with AV material to 8-12 patients
(3) Control group
Outcomes (1) Proportion of patients in each group with uncontrolled hypertension (SBP <160, DBP <95mmHg)-
within group increase reported for both intervention arms, individual 50.4% to 60.9%, team, 55.8% to
68.8%, non significant within group change in control group, 54.4% to 58.9%
(2) Patient knowledge- no between group difference, individual 19.79, Team 20.58, control 19.78
Duration of FU: 2 months
Notes Knowledge increased within all 3 groups over time, between group comparison not statistically tested
No baseline numbers per arm of study reported
% control BP not included in meta-analysis as no denominator data available at start of RCT
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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McAlister 1986
Methods Cluster (60 doctors initially, 10 dropped out), parallel, Toronto Canada
Participants N=50 general practitioners, 1241 (E) 990 (C), hypertensive patients with one of the following:
(1) DBP >90 mmHg on treatment
(2) DBP >104 mmHg not on treatment
(3) DBP >90 or <105 mmHg unless evidence of complications or risk factors
(4) Newly detected patients with ”high blood pressure“ detected during the trial
Interventions (1) Computer generated feedback to physician:
”Cumulative chart of patient’s DBP
“Inter and Intra practice DBP ranking
”Commentary on treatment by GP according to a “stepped care” approach
(2) Control group filled out same forms but no feedback given
Outcomes 1)Workload: GPs in experimental group saw more patients
(2) Mean score on length of follow up: better in intervention 199.3 days (E) vs 167days (C)
(3) Drop outs: 37.5% (E) vs 42.1% (C)
(4) In all patients DBP reading in those with initial DBP > 104mmHg: 88.5mmHg (E) vs 93.3mmHg
(C), net DBP change 0.8mmHg P <0.1
(5) % patients with controlled DBP ( 90mmHg)- 88.9% (E) versus 87.5% (C) NS
(6) # days with sustained DBP control 323 (E) vs 259(C)
(7) # times visited GP: 13.3 (E) vs (17.4)
Duration 16 months
Notes Multiple outcomes reported, some favourable for experimental arm- sawmore patients who were less likely
to drop out of care. Doesn’t appear to have had an impact on overall DBP control but other measures of
BP control favoured intervention group such as number of days with sustained DBP control. This was
achieved with fewer visits in the intervention group
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
McKinstry 2006
Methods Parallel, single blind, Single urban general practice over 1 year in the UK
Participants Patient-held guideline with written explicit exhortation to challenge care when appropriate. Two hundred
and ninety-four of 536 eligible patients on the practice hypertension register were recruited, all of whom
were randomised into one of two groups. Two hundred and thirty-six patients completed the study. All
>18 years with one SBD >150 were invited to take part. No exclusions
Interventions Primary outcome: average systolic blood pressure. Secondary outcomes: proportion of patients with blood
pressure < 150 mmHg systolic and < 90 mmHg diastolic, average cholesterol, proportion of patients
prescribed statins and aspirin according to guideline, hospital anxiety and depression score
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McKinstry 2006 (Continued)
Outcomes Primary outcome: average systolic blood pressure. Secondary outcomes: proportion of patients with blood
pressure < 150 mmHg systolic and < 90 mmHg diastolic, average cholesterol, proportion of patients
prescribed statins and aspirin according to guideline, hospital anxiety and depression score. No clinically,
or statistically significant differences were found between intervention and control with respect to all
parameters or in anxiety and depression levels. Statin and aspirin use improved throughout the course of
the study in both groups. Statin use showed a trend (P = 0.02) in favour of control
12/12 follow up
Notes Only absolute values for BP measure, control data entered
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
McManus 2005
Methods Parallel, in eight general practices in south Birmingham
Participants 441 people receiving treatment in primary care for hypertension but not controlled below the target of <
140/85 mm Hg
Interventions Patients in the intervention group received treatment targets along with facilities to measure their own
blood pressure at their general practice; they were also asked to visit their general practitioner or practice
nurse if their blood pressure was repeatedly above the target level. Patients in the control group received
usual care (blood pressure monitoring by their practice)
Outcomes Primary outcome: change in systolic blood pressure at six months and one year in both intervention and
control groups. Secondary outcomes: change in health behaviours, anxiety, prescribed antihypertensive
drugs, patients’ preferences of method of blood pressure monitoring, and costs
400 (91%) patients attended follow up at one year. Systolic blood pressure in the intervention group had
significantly reduced after six months (mean difference 4.3 mm Hg (95% confidence interval 0.8 mm
Hg to 7.9 mm Hg)) but not after one year (mean difference 2.7 mm Hg (- 1.2 mm Hg to 6.6 mm Hg)
). No overall difference was found in diastolic blood pressure, anxiety, health behaviours, or number of
prescribed drugs. Patients who self monitored lost more weight than controls (as evidenced by a drop in
body mass index), rated self monitoring above monitoring by a doctor or nurse, and consulted less often.
Overall, self monitoring did not cost significantly more than usual care (251 pounds sterling (437 dollars;
364 euros) (95% confidence interval 233 pounds sterling to 275 pounds sterling) versus 240 pounds
sterling (217 pounds sterling to 263 pounds sterling)
12 months follow up
Notes Well desgined study carried out in primary care.
Risk of bias
Item Authors’ judgement Description
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Allocation concealment? Yes A - Adequate
Mehos 2000
Methods Parallel, individuals in a single family medicine clinic, US
Participants 41 uncontrolled hypertensives, SBP 140-179mmHg and/or DBP 90-109mmHg, currently on treatment,
mean age 59 years, 70% women
Interventions (1) Home blood pressure monitoring, diary and instruction to measure blood pressure, information on
hypertension and risk factors, subsequent evaluation by clinical pharmacist (2) Usual care
Outcomes (1) SBP, DBP and mean BP- all reduced in (E) group, SBP (E) 140.8mmHg versus (C) 146.9mmHg (p=
0.069), DBP (E) 80.6mmHg versus (C) 85.6mmHg (p=0.02),
(2) Compliance (self report)- mean adherence 82% (E) vs 89% (C) (p=0.29)
(3) Drug alteration (dosage increase, addition or switch)- 83% (E) vs 33% (C) (p=0.29)
(4) Quality of life (SF36)- no difference between groups
Duration of FU 6 months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Midanik 1991
Methods Parallel, individuals, from a single foundation health plan in California, US
Participants 204 untreated hypertensive patients with “mild” hypertension- SBP <180mmHg and DBP 90-99mmHg
Interventions (1) Self monitoring- patients trained to take two consecutive readings twice a week. Sent in readings every
4 weeks for one year (2) Usual care
Outcomes (1) Blood pressure- mean change SBP -1 mmHg, mean change DBP -1 mmHg (E) versus mean change
SBP +1 mmHg, mean change DBP -1 mmHg Duration of FU 1 year
Notes Untreated subjects with 18% of (E) and 17% of (C) patients taking antihypertensive medication at the
end of the RCT
Risk of bias
Item Authors’ judgement Description
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Midanik 1991 (Continued)
Allocation concealment? Unclear B - Unclear
Montgomery 2000
Methods 27 general practice in UK, Cluster RCT, patients on register
Participants Hypertensive patients aged 60-80 taking BP lowering drugs.
Randomly selected from practice register
Interventions (1) Computer based decision support system (CDSS)
(2) Risk chart
Both interventions provided health professional (general practitioner or practice nurse) with explicit
cardiovascular risk. Based on New Zealand hypertension guidelines.
(3) Usual care
Outcomes (1) Cardiovascular risk- no change in CVD risk between 3 groups
(2) SBP/DBP- adjusted analysis, chart group had better mean SBP reading than usual care (difference 4.
6mmHg)
(3) Proportionof patientswith controlled hypertension (<160/90)- nodifference between two intervention
groups chart 39.7%, CDSS 47.5% and control 40.7%
(4) Medication change- intensity of BP medication prescribing greater in chart group compared to usual
care
Duration of FU 1 year
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Morisky 1983
Methods Factorial trial with 8 groups of various combinations of the 3 interventions and control individuals at two
hypertension clinics in US
Participants 91% black, median age 54 years, 70% female, low income ($45250 median yearly income).
BP (mmHg) entry criteria based on age:
20-39: >140/90
40-59: >150/95
60: 160/100
Interventions (1) Three interventions:
“Exit interview- individualised 5-10 minute counselling session, explaining and re-inforcing instructions
to the patient
”Instructional session with adult at home concerning adherence and follow up care
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Morisky 1983 (Continued)
“Group sessions- three, one hour sessions led by social worker
”Seven experimental groups and one control group
(2) Usual care with none of above interventions
Outcomes (1) Deviation in weight from ideal weight- significantly better in patients who received all 3 interventions
compared to those who received none
(2) Appointment keeping (ratio of kept/scheduled)- improved in group who received all 3 interventions
versus control at 2 yrs (E) .68 versus (C) .63; no difference at 5 yrs (E) .95 versus (C) .83
(3) Adherence to drug therapy- all improved, greatest in 3 intervention arm versus control (53% vs 40%)
(4) % patients with controlled BP - increased at 2 years (E) 52% versus (C) 42%; 5 years (E) 66% versus
(C) 56%. Significantly better in four intervention groups compared to control at 5 years
(5) All cause mortality- cumulative mortality better in all experimental groups combined (12.9) compared
to control group (30.2)
(6)Cost effectiveness-multiple interventions appearmore effective, not necessarilymore cost effective. Au-
thors feel that may be better to use single interventions depending on setting and financial constraints{821}
Duration of FU 2 and 5 years.
Notes Multiple comparisons in results section: 7 intervention arms and one control group
In addition no a priori sub-group analysis
Blood pressure control age-specific categories
<40 <140/90,
40-59 <150/95
60, <160/100
Substantially greater numbers lost to follow up in (C) arm at 2 and 5 years
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Muhlhauser 1993
Methods 10 general practices Germany, 20 hypertensive patients randomly selected (age 30-60 years)
Participants Hypertension (mean last 2 measurements 160 and/or 95). Taking BP medication (E 77%, C 86%)
Interventions (1) Hypertension treatment and teaching programme (HTTP) consisted of:
”Four consecutive meetings lasting 60-90 mins in groups of 4-6.
“Provided by physician assistants
”Responsibility including BP self monitoring
“Confirming diagnosis and treatment by using home BP measurements
”Emphasis on non-pharmacological treatment
Doctors (8 hours) and assistants (20 hours) in intervention practices attended preparatory course but
RCT aimed principally at patients
(2) Usual care
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Muhlhauser 1993 (Continued)
Outcomes (1) Change in SBP/DBP- significantly improved at follow up, difference SBP 5mmHg, DBP 4mmHg
(2) Proportion of patients with controlled hypertension (<140/90)- no difference (E) 14% versus 15%
(C)
(3) # BP drugs taken
Duration of FU 18 months
Notes (1) Only 46 (46%) in intervention group received intervention (2) Cluster RCT not accounted for design
or analysis.
(3) Well conducted RCT but differential losses to FU
(4) Less people in intervention group taking BP medication at end of RCT (mean # (E)- 1.2, (C) 1.8)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
New 2004
Methods Cluster RCT General practices
Participants 44 general practices, Salford, UK, 10303 participants
Interventions (1) Educational outreach: specialist nurses arranged a schedule of visits with general practitioners and
practice nurses, reminding them of protocols and clinical targets; provided educational material and pro-
tocols used in secondary care for nurse and doctor interventions including stepping up pharmacotherapy
when necessary. (2) usual care
Outcomes (1) Proportion of participants reaching blood pressure target/OR: no difference between groups OR 1.01
(95% CI 0.8 to 1.3, p=0.93)
Notes Study funded by pharmaceutical company.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Ornstein 2004
Methods Cluster RCT, 20 community-based family or general internal medicine practices in 14 US states. 44
physicians, 17 ”midlevel“ providers and approximately 200 staff members
Participants Of 87,291 patients from 20 practices, 7772 (8.9%) with hypertension. At baseline 40% (E) and 43.7%
(C) had ”controlled“ blood pressure (<140/90).
21 study indicators included:
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Ornstein 2004 (Continued)
-Hypertension (5) including most recent BP measurement <140/90 for patients with a diagnosis of
hypertension
-Hyperlipidemia (2)
-Coronary heart disease (6)
”Heart failure (1)
-Atrial fibrillation (1)
-Diabetes (6)
Interventions (1) Multi-method quality improvement (QI)-
-Practice site visits (6-7, 1-2 day site visits in a two year period) involving physicians and pharmacist with
expertise in academic detailing. Healthcare providers encouraged to use (QI) tools
-Two-day networkmeetings in each study year. Initial meeting directed at lead clinicianwith “best practice”
presentations made by participating clinicians who were performing well. Clinical and administrative staff
attended second meeting
(2) Usual care- received copies of practice guidelines and quarterly performance reports
Outcomes (1) Control BP <140/90mmHg improved 58.4% (E) versus 51.9% (C), adjusted difference 8.0 (0.0 to
16.0), p=0.047
Duration of FU 2 years
Notes General multi-method across 6 conditions and 21 quality indicators. Overall intervention practices im-
proved 22.4 percentage points in terms of indicators at or above target, compared to 16.4 in control
practices, difference 6.0 percentage points (p>0.2).
Patients in intervention practices had greater improvements than control practices for diagnosis of hyper-
tension and blood pressure control
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Park 1996
Methods Parallel, individuals two pharmacies, US
Participants TakingBP lowering treatment or hadBP140/90mmHg.mainlywhite treated hypertensives, 50%women,
mean age 60 years
Interventions (1) Pharmacist administered monthly patient management including education, medication changes,
verbal counselling and written information on hypertension and risk factors
(2) Traditional pharmacy services
Outcomes (1) SBP/DBP- improved SBP (E) 143.2mmHg versus (C) 148.6mmHg, DBP (E) 83.2mmHg versus (C)
83.7mmHg, no between group p values reported
(2) Control of blood pressure (<140/90 mmHg)- improved 52.2% (E) vs 17.4% (C), p<0.02
(3) Compliance (pill counts, unaware)- mean adherence 86.8% (E) vs 89.1% (C) no p value reported
(4) Self reported quality of life- in general higher in (E) vs (C) group
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Park 1996 (Continued)
(5) Time spent with patient- higher in (E) group, particularly at first visit
Duration of FU 4 months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Pierce 1984
Methods Factorial, individuals, single general practice clinic, Western Australia
Participants Uncontrolled hypertensives (SBP 160 and/or DBP 95) taking BP medication, mean age 57 years, 60%
women,
Interventions (1) Self monitoring of blood pressure: 30 min briefing, monthly recording chart
(2) Health education programme promoting a healthy cardiovascular lifestyle: four meetings, 90 min
duration, max 12 participants, encouraged tomake action goals, information (risk factors for heart disease,
stress, diet)
(3) Both interventions
(4) Usual care
Outcomes (1) Blood pressure control- Education: 83% (E) vs 67% (C) (p<0.05, effect size unclear) p<0.05 Moni-
toring: 74% (E) vs 78% (C) NS
(2) Compliance (pill count, self report)- No significant difference between groups: Education: 27% good
adherers versus 24% in control group.
Monitoring: 30% Both interventions: 26%
(3) Patient Knowledge- no difference
Duration of FU 12 months
Notes Health education appears more beneficial in controlled blood pressure than self monitoring.
Blood pressure reduction, target blood pressure level not defined
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Robson 1989
Methods Parallel, individuals based in a single family practice in UK
Participants Patients registered in the practice. Age 30-64. Also concerned with recording and follow up of other
cardiovascular risk factor data and cervical screening follow up
Interventions (1) Recording and follow up of blood pressure and other cardiovascular risk factors with practice nurse or
general practitioner aided by computer
(2) Usual general practitioners follow up
Outcomes (1) Blood pressure recording in all patients- increased 1511/1620 (E- 93%) 1160/1586 (C- 73%)
(2) Blood pressure recording in hypertensive patients- increased 104/107 (E- 97%) 90/116 (C- 69%)
(3)Other cardiovascular risk factors- all increased recording in intervention group, smoking, family history
and cholesterol
Duration of FU 2 years
Notes Improved recording of blood pressure and other cardiovascular risk factors
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Roca-Cusachs 1991
Methods Parallel, individual in a hypertension clinic, Spain
Participants Newly diagnosed hypertensive patients (excluded age >70, illiterate and ”high probability of non atten-
dance“) Entry SBP/DBP noted but no threshold required for eligibility. Mean values were:
(E) 156.3/95.8
(C) 160.3/96.1
Interventions (1)Patient education-
”Booklet at initial entry into study
“Two educational talks. First educational talk given by pharmacist and doctor, covered information about
hypertension, treatment adherence and appointments; second educational talk given by dieticians covered
non-pharmacological treatments.
”Personal tutorial meeting one month later- solve problems, clarify misunderstandings and re-enforce
knowledge.
(2) Usual care
Outcomes (1) Weight- no difference
(2) Mean SBP/DBP- no difference
(3) Withdrawals- 39% (E) vs 26% (C) significant difference
(4) Knowledge questionnaire- improved knowledge in (E) group
(5) Number of BP pills taken- no difference
(6) Biochemical markers- no difference
Duration of FU 6 months
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Roca-Cusachs 1991 (Continued)
Notes (1) Knowledge improved, other outcomes no difference, withdrawal from the programme greater in the
(E) 39% versus (C) 25%
(2) Large proportion of (E) failed to attend an educational session, 83/138 (60%).
(3) Sub-group analysis showed that 55/138 (40%) who attended one or more educational session did not
have a different outcome in terms of all outcome measures at follow up, including SBP/DBP than those
in intervention group who failed to attend sessions 83/138 (60%), except that those who attended had
significantly higher probability of not withdrawing overall 3.6% vs 63%
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Rogers 2001
Methods Medical outpatients department, patients covered by insurance under care of 5 internists, New York state,
US
Participants Previous diagnosis of hypertension but were being considered for change in BP medication because:
(1) SBP 140 or DBP 90 despite current antihypertensive therapy
(2) Side effects from drugs
(3) SBP >180 or DBP >110 without current antihypertensive therapy
Interventions (1) Telecommunication service with 3 components:
”Automated BP at home with no self report
“Central processing of BP readings
”Weekly reports to both physician and patient. When physicians received report forms that indicated
increased blood pressure they adjusted BP medication via telephone call, office visit or both. Readings
minimum of 3 days each week for minimum 8 weeks
(2) Usual care
Outcomes (1) Mean change in arterial blood pressure- improved -2.8mmHg (E) versus +1.3 (C) p=0.013
(2) Mean change in systolic blood pressure- improved -4.9mmHg (E) versus -0.1 (C) p=0.047
(3) Mean change in diastolic blood pressure- improved -2mmHg (E) versus +2.1 (C) p=0.012
Median duration of FU 11 weeks
Notes Change in mean arterial BP primary outcome via 24 hr ambulatory reading
Change in BP medication related to change in mean arterial BP and was more common in intervention
group, 33% (E) versus 7% (C) group.
No change in median number of office visits
Difference in median length of FU (longer in intervention group, 79 vs 72 days)
Satisfaction with care same in both groups
Risk of bias
Item Authors’ judgement Description
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Rogers 2001 (Continued)
Allocation concealment? Yes A - Adequate
Rudd 2004
Methods Parallel RCT, two medical clinics
Participants Hypertension- SBP ?140 mmHg or DBP ?90mmHg in previous six months or history of drug treatment.
Drug therapy for patients with 150 mmHg or DBP 95 mmHg
Interventions (1) Self measurement with nurse management based on algorithm. Twice daily measurement, after 14
measurements mailed to nurse care manager who used this BP data to give management. Additional
interventions included tips on enhancing drug adherence and recognition of possible side effects; printed
materials; follow up calls at 1 week, 1, 2 and 4 months. Nurse contacted physicians to initiate new drugs
not did not contact physicians when changing medication dosage. Increase in drug dose occurred when
<80% measurements met criterion of 130/85mmHg. (1)
Outcomes Usual care
Notes (1) Blood pressure- mean change DBP -6.5 mmHg (E) versus mean change DBP 3.4 mmHg (C) (2)
Increase in taking and intensification of antihypertensive drugs-22% (E) and 30% (C) patients taking
antihypertensive medication, changed to 96% (E) and 78% (C). Significant increase in number taking ?
drugs 70% (E) and 46% (C). (3) Improved adherence tomediation-80.5% (E) versus 69.2% (C)Duration
of FU 6 months
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sackett 1975
Methods Factorial RCT
Steel mill employees in Canada
Participants Hypertension 95mmHg on repeated measurement. Not currently treated. n=230
Interventions (1) Augmented convenience (AC)
Saw on-site physicians during working hours and on full pay versus usual care of seeing their own GP
(2) Mastery learning (ML)
Educational programme designed to give them the facts about hypertension, including compliance advice
and reminders about pill-taking. Information supplied in audio-casette and booklet. Mastery learning re-
emphasised by a “patient educator”
(3) Both intervention
(4) Usual care
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Sackett 1975 (Continued)
Outcomes (1) Number men placed on BP medication increased in both groups
AC (87/114, 76% vs 57/116, 49%)
ML (80/115, 70% vs 64/115, 56%)
(2) Compliance- no difference
AC (47/87, 54% vs 29/57, 51%)
ML (40/80, 50% vs 36/64, 56%)
(3) Compliance and at goal BP (<90mmHg)- no difference
AC (20/87, 23% vs 11/57, 19%)
ML (19/80, 24% vs 12/64, 19%)
Duration of FU 6 months
Notes Knowledge improved significantly in the Mastery learning group (85% vs 18%).
Individual compliance rates bore no relationship to knowledge
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sanders 2002
Methods Cluster RCT, two of three primary care group practices, Virginia, US. 22 primary care physicians
Participants Hypertension and diabetes, 30 years of older, on medication for both conditions, blood pressure ”greater
than normal“ on an index visit
Interventions (1)Chart reminder- consisted on a bright cardstock consisting of information on the following: description
of the problem; recommended target blood pressures, algorithm for suggested care (modified from US
JNC VI guidelines). Participating physicians not reminded in any other way
(2) Usual care
Outcomes (1) Blood pressure- mean SBP 148mmHg (E) versus 150.87, p=0.14, mean DBP 75.14mmHg (E) versus
77.21mmHg (C), p=0.16
(2) Medication change- 31% (E) versus 36% (C), p=0.51
Duration of FU ”as soon as feasible after the chart reminder was placed and the clinic visit conducted
Notes Cluster RCT analysed at individual level
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
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Schroeder 2005
Methods To evaluate the effect of nurse-led adherence support for people with uncontrolled high blood pressure
compared with usual care
Participants 245 women and men recruited with uncontrolled hypertension (> or = 150/90 mmHg) from 21 general
practices in Bristol, UK
All patients with hypertension coded and latests SBP ?150 and/or DBP 90 in last 6 months
Interventions Participants were randomized to receive nurse-led adherence support or usual care alone
Outcomes Main outcome measures were adherence to medication (’timing compliance’) and blood pressure
Duration:6 months
Notes absolute only
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Soghikian 1992
Methods Parallel, 430 individuals in four medical centres, California, USA referred by 67 physicians
Participants Hypertension but no entry BP level required or defined. DBP <90mmHg in 60% (C) 59% (E), 90-
104mmHg 33% (C) 37% (E), 105mmHg 7% (C) 4% (E) patients. 82% (C) 88% (E) patients taking
BP lowering medication.
14% had end organ damage of cardiovascular event during the year of the trial
Interventions (1) Home blood pressure measurement- patients asked to measure BP twice weekly, mail record of BP,
medications and side effects to project office every 4 weeks. Data compiled and sent to each patient’s
physician. Non compliant patients were contacted and urged to submit readings.
(2) Usual care
Outcomes (1) Use of medical services- mean number hypertension related office visits 1.2 less in (E) group, telephone
calls 0.8 more in (E) group, procedures per patient the same.
(2) Cost of services- mean cost significantly lower $88.28 (E) vs $125.37 (C)
(3) Blood pressure control lower in (E) group - mean SBP (E) 135.9mmHg versus (C) 142mmHg
unadjusted difference-6.1mmHg NS; DBP (E) 86.2mmHg versus (C) 88mmHg, unadjusted difference
-1.8mmHg. NS
(4) Patient and physician satisfaction- high for (E) group
Duration of FU 1 year
Notes Costs lower in (E) group (29%) with a non significant trend in reduction of SBP/DBP
Risk of bias
Item Authors’ judgement Description
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Soghikian 1992 (Continued)
Allocation concealment? Unclear B - Unclear
Solomon 2002
Methods Parallel, individuals from ten departments of Veterans Affairs medical centres and one academic medical
centre, US
Participants Treated hypertensive patients (dihydropyridine and/or diuretic therapy) (n=133), 64% caucasian, 28%
black, 96% men, mean age 67 years,
Interventions (1) Patient-centred pharmaceutical care model (employing standardised care) implemented by clinical
pharmacy residents, scheduled visits at one-month intervals for a total of five visits
(2) Usual care
Outcomes (1) Blood pressure control- SBP improved (E) 138.5mmHg versus (C) 144.9mmHg (p<0.05), DBP (E)
80.2mmHg versus (C) 83.2mmHg NS
(2) Compliance (pill count, self report)- better compliance scores (0.23 vs 0.61) in (E) group (p<0.05)
(3) Mean number of hospitalisations/other health care provider visits- significantly higher in (C) group
Duration of FU 6 months
Notes Losses to follow up not reported
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Sookaneknun 2004
Methods Pre-test, post-test controlled group study.
Participants Adults with hypertension from hospital and 2 primary care units
Interventions Patients were monitored monthly by reviewing their medications and supported by providing pharma-
ceutical care and counseling
Outcomes Systolic and Diastolic BP; % achieving targets
Notes From a total of 235 patients, the treatment group (n = 118) had a significant reduction in both systolic (S)
and diastolic (D) BP compared with the 117 patients of the control group (p = 0.037, 0.027, respectively)
. The 158 patients (76 treatment, 82 control) with BPs >or=140/90 mmHg at the beginning of the study
showed significant BP reductions (p = 0.002 SBP, 0.008 DBP). The proportion of 158 patients whose BP
became stabilized was higher in the treatment group (p = 0.017)
Risk of bias
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Sookaneknun 2004 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Takala 1979
Methods Hypertensive patients identified through systematic screening of 1245 individuals. To be included had to
have two BP readings, six months apart with high blood pressure on not on BP treatment
Participants Hypertensive patients in Finland, n=147, aged 40-49, SBP 160mmHg or DBP 95mmHg; aged 50-64,
SBP 170mmHg or DBP 105mmHg. Drug treatment started in 78/93 (84%) in intervention group and
86/100 (86%) in control group
Interventions (1) “Improved treatment system” included: Written treatment instructions. Card with details of BP read-
ings, drugs prescribed, time of next appointment. Appointments at one monthly intervals. Invitation for
outpatient review; appointment if defaulted on any appointment. (2) Usual care
Outcomes (1) “Dropping out” of system- failing to keep outpatient follow up appointment. Improved in (E) 3/100
versus (C) 16/102 (2) Control of SBP/DBP reported separately in two age groups (aged 50) (3) % patients
in each group who attained BP goal, 31% (E) vs 17% (C) Duration of FU 1 and 2 years
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Takala 1983
Methods Hypertensive patients identified through systematic screening of 1245 individuals. To be included had to
have two BP readings, six months apart with high blood pressure on not on BP treatment
Participants Hypertensive patients in Finland, aged 40-49, SBP 160mmHg or DBP 95mmHg; aged 50-64, SBP
170mmHg or DBP 105mmHg. Drug treatment started in 78/93 (84%) in intervention group and 86/
100 (86%) in control group
Interventions (1) “Improved treatment system” included: Written treatment instructions. Card with details of BP read-
ings, drugs prescribed, time of next appointment. Appointments at one monthly intervals. Invitation for
outpatient review; appointment if defaulted on any appointment. (2) Usual care
Outcomes (1) “Dropping out” of system- failing to keep outpatient follow up appointment. Improved in (E) 3/100
versus (C) 16/102 (2) Control of SBP/DBP reported separately in two age groups (aged 50) (3) % patients
in each group who attained BP goal, 31% (E) vs 17% (C) Duration of FU 1 and 2 years
Notes
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Takala 1983 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Tanner 1981
Methods Hypertensive patients attending in a single urban family practice.
Both groups visit family practice every 2 weeks for 4 months- total 8 appointments
Participants Diagnosis of hypertension from computer search with DBP 90mmHg, age 18-65. 50 identified, 30 agreed
to participate, 11 males. 14 black
Interventions (1) Intervention group given “Guide to essential hypertension” content included: hypertension; medica-
tion; diet; stress; exercise; smoking; lifestyle; BP monitoring techniques. Encouraged to ask questions and
discuss problems when they at practice visits.
(2) Usual care
Outcomes (1) Knowledge- baseline and follow up-within group comparison knowledge
E-13.53 to 14.40 increase
C- 13.26 to 13.26 no change.
Between group score significantly better in E versus C group.
(2) Control of DBP- no difference
Duration of FU 4 months
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Tobe 2006
Methods Hypertensive diabetic First Nations patients
registered through community screening clinics, home care nurses, health aides
randomized, prospective, open-label study with 2 parallel groups
693 patients were assessed for eligibility, Canada
Participants Diagnosis of hypertension
with SBP greater or equal to 130mmHg
DBP greater or equal to 80mm Hg
Diagnosis of type 2 diabetes mellitus
99 identified, 95 agreed to participate 48 intervention group, 47 control group
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Tobe 2006 (Continued)
Interventions (1) Medical clinic measurement of blood pressure by home care nurse using BpTRU automated oscillo-
metric blood pressure cuff
(2) Healthy lifestyle classes stressing a healthier dietary regimen, exercise, smoking cessation and drug
adherence
Outcomes (1) Primary outcome measure: mean change in SBP from baseline to the final visit in the intervention
group compared with the control group
(2) Secondary outcome measure: mean change in DBP over time in the 2 groups, change in urine albumin
status and incidence of adverse events
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear D - Not used
Tonstad 2007
Methods RCT
Participants Subjects that participated in a health screening with systolic blood pressure 140-169 mmHg and diastolic
blood pressure 90-99 mm Hg at a minimum of three separate readings treated or not treated with
antihypertensive drugs
Interventions Randomly allocated either to monthly nurse-led lifestyle counselling (intervention group, N=31) or to
conventional primary care (control group, N=20) to be followed by lifestyle counselling
Outcomes Systolic and diastolic BP
Notes The mean (S.D.) baseline and end of study blood pressure was 157 (9)/94 (6) mm Hg and 147 (9)/91
(8) mm Hg, respectively, in the intervention group versus 153 (9)/94 (4) and 143 (10)/92 (8) mm Hg,
respectively, in the control group (NS between the groups)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Turnbull 2006
Methods pilot cluster randomized controlled trial (stratified for rurality) of 67 general practices (including 371
patients) across two Australian states
Participants Persons were eligible if had mild to moderate hypertension (i.e., mean systolic BP of ? 140 mmHg and/or
mean diastolic BP, DBP, of ? 90 mmHg on 3 separate occasions during a 3-week period), and were able
to complete the questionnaire unaided and aged between18 and 75 years.
Source of patients: A proposed study group consisted of all persons n (N = 320) who had visited the
outpatient hypertension clinic between November 2000 and September 2001. 76 eligible but 6 did not
consent
Interventions The central platform of this program is an information communication technology package for risk
assessment and management, access to a dietitian commissioned by the program and a tailored set of
audiovisual and written material.,
Outcomes The primary outcome was SBP, which was measured after a 6-month interval. Additional outcomes
included DBP, fasting lipids, obesity parameters, alcohol consumption, smoking, and stress management
at
6 months follow-up.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Vetter 2000
Methods Parallel, individuals 244 practitioners in Switzerland, 4 patients per practitioner recruited
Participants Hypertension, SBP 160-200mmHg or DBP 95-115mmHg in untreated patients or uncontrolled patients
or who wished to change BP lowering drug because of low tolerance
Interventions (1) Home measurement of blood pressure by patients
(2) Usual care
Outcomes (1) Blood pressure control- SBP improved (E) 145.1mmHg versus (C) 147.6mmHg(p=0.02), DBP im-
proved (E) 88.7mmHg versus (C) 90.1mmHg (p=0.038). (2) % with controlled hypertension (DBP
90mmHg) 66.2% (E) vs 59.8mmHg (ns)
Duration of FU 8 weeks
Notes All patients treated with same BP lowering drug, Losartan 50mg once daily. No compliance data so not
possible to say improved BP control due to improved compliance. Home BPmeasurement produced small
BP change at 8 weeks
Risk of bias
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Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Watkins 1987
Methods 6 General practices UK
n=414, 41% male
Participants Hypertension determined from medical records age range 35-64
Interventions (1) Information booklet on hypertension sent out to patients
(2) Usual care
Outcomes (1) (1) Systolic blood pressure- no difference 149.2mmHg (C) versus 149.8mmHg (E)
(2) Diastolic blood pressure- no difference 94.9mmHg (C) versus 95.3mmHg (E)
(2) Knowledge- slight increase in knowledge score in intervention group
Duration of FU 1 year
Notes Drop outs not reported in each arm
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Webb 1980
Methods Parallel, individuals who were patients of 14 family practice residents US
Participants Patients had to have at least: one year history of hypertension; uncontrolled DBP 90mmHg; taking BP
lowering drugs
Interventions (1) Education- three group education sessions by nurse-health educator (causes, nature, implications and
treatment of hypertension)
(2) Counselling- three “individualized” counselling sessions
(3) Usual care- three appointments with family physician
Outcomes (1) DBP- no difference between either group and usual care- education (E1) 88.9mmHg versus (C) 88.
1mmHg, counselling (E2) 87.4mmHg versus 88.1mmHg
(2) Compliance- no difference between either group and usual care
(3) Return for follow up appointment- no difference education (E1)10.1 versus (C) 10.2, counselling
(E2) 11.2 versus 10.2
Duration of FU 6 months
Notes Negative RCT, data pooled from education arm of trial
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Webb 1980 (Continued)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Wetzels 2007
Methods Parallel RCT, This study was designed to evaluate the effectiveness of electronic monitoring of adherence
in lowering blood pressure (BP) in comparison with usual care
Participants 43Gps inHolland, Number of patients randomised: 258 (168 C. and 90 I.) 2:1 randomization employed,
Number of patients analysed: 253 (164 C. and 89 I.)
Persons were eligible if had been diagnosed with hypertension (? SBP 160 or DBP 95) and inadequate BP
control despite drugs and indication for Rx escalation
Interventions A total of 258 patients with high BP despite use of antihypertensive medication were randomly assigned
to either continuation of usual care (with adjustment in antihypertensive medication if necessary) or to
the introduction of electronic monitoring. Adherence to antihypertensive medication was monitored for
2 months without medication changes
Outcomes The primary outcome measure was the proportion of patients who reached target BP levels after a 5-
month follow-up period
At 5 months, 50.6% of the patients in the usual care group reached adequate BP, v 53.7% in the electronic
monitoring group (P = .73). The percentages of patients with drug additions or increases in dosage
were higher in the usual care group compared with those in whom adherence was monitored (P < .01)
. CONCLUSION: These data show that electronic monitoring in comparison to usual care results in
similar BP control but leads to fewer drug changes and less drug use. This result is likely to be achieved by
improving adherence. Hence a strategy that includes electronic monitoring has the potential to prevent
unnecessary treatment escalation in patients with poor adherence
Notes Not sure if the intervention fits here or where? Good data for entering (not done)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Zarnke 1997
Methods Parallel individuals from eleven family physicians and one tertiary hypertension research unit, Canada
Participants Age 52 (E) 56 (C), 13 (42%) male, average BP readings <160/95, taking BP lowering drugs or receiving
non-pharmacological advice
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Zarnke 1997 (Continued)
Interventions (1) Patient-directed group - instructed in home BP measurement, measured own BP twice daily and
instructed by means of algorithm to change own BP medication, if still exceed goal to contact family
doctor
(2) Office-based group- adjustments to BP medication made by family doctor
Outcomes (1) Change in daytime mean arterial BP adjusted for baseline measurement- decreased significantly in (E)
group -0.95 versus +1.9 (C)
(2) Compliance (doses missed per week- (E) 0.05 versus (C) 0.2 NS
(3) Quality of life scores- no difference
(4) Indices of health care resource use- total number of physician visits significantly greater in (E) group,
no difference in total number of BP drugs used
Duration of FU 8 weeks
Notes Small RCT (n=31), short period of follow up
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Zismer 1982
Methods Hypertensive patients in a single urban family practice. 176 eligible, 50 randomly selected, 39 agreed to
take part.
3 groups- two separate intervention groups treated as the same in the analysis
Participants Diagnosis of hypertension or receiving BP lowering drugs or elevated BP for 2 consecutive visits 140 or
90mmHg within previous 12 months
37 black, 21 male, average age 45 (E) 56 (C), age range 21 to 76
Interventions (1) Experimental group A- Educational “self-care” intervention: pill taking; appointment keeping; dietary
sodium reduction
(2) Experimental group B-received additional support from family member.
(3) Usual care
Outcomes (1) Systolic blood pressure- improved 150.9mmHg (C) versus 130.5mmHg (E), p<0.01.
(2) Diastolic blood pressure- improved 92mmHg (C) versus 85mmHg (E), p<0.001.
(3) Frequency of visits- no difference between groups in mean number of visits
Duration of FU 6 months
Notes BP readings at baseline and FU were mean of last 3 readings
Control group was not similar to experimental group: 10 years older and diagnosed for longer
Risk of bias
Item Authors’ judgement Description
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Zismer 1982 (Continued)
Allocation concealment? Unclear B - Unclear
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Andrejak 2000 Randomised trial of once daily versus twice daily ace inhibitor. Outcome compliance as judged by mem’s
monitored. Once daily medication better than twice daily dosage. Included in adherence systematic review.
Excluded: adherence RCT
Artinian 2007 Control group not a proper control group as received enhanced usual care
Asmar 2007 Not a RCT: ‘preselected’ GP’s were randomised and then asked to include the first 4 consecutive eligible
patients agreeing to participate. No record of eligible patients who did not participate
Bachman 2002 Accuracy and quality of self-reported home blood pressure values assessed. 48 patients randomised to receive
information about storage capabilities of a home measuring device or not. Accuracy and interpretation of
home blood measurement increased in the informed group. Reason for exclusion: intervention not aimed
directly at improving blood pressure control; no blood pressure data reported
Barron-Rivera 1998 Randomised trial of education programmed to patients. Outcome was well-being and quality of life. Ex-
cluded: no report on blood pressure control in the process of care
Ben Said Randomised trial of assessment education interventions - same trial as reported by Consoli. Excluded: no
outcome on blood pressure or process of care reported
Binstock 1988 Excluded because no ”usual care“ group.
Birtwhistle 2004 Equivalence RCT of three month versus six month follow up.
Reason for exclusion:
(1) Neither intervention met inclusion criteria of the review. No additional intervention directed at either
patient, health professional or organisation of care.
Finding that BP control was equivalent between three and six month follow up arms of the study. Both
groups saw health professional much more often than planned over the three years- mean (sd) visits per
patient in three month group 18.8 (8.06) versus 16.2 (8.45) in six month group
Blenkinsopp 2000 Parallel, cluster randomised, 20 community pharmacy sites, UK. 180 treated hypertensives, 62% age 60 or
over. (1) Pharmacist delivered, Structured, brief questioning protocol on medication problems; including
advice, information and referral to general practitioner versus usual care, delivered three times at two-month
intervals
(2)Usual care. (1)%with controlled hypertension- of those patients with initially uncontrolled hypertension
( 160/90mmHg) (E) 35.7% versus (C) 17.1% were controlled at follow up (p<0.05), no difference in BP
control in those who were controlled at start of study
(2) Compliance (self report)- 62% (E) versus 50% (C) (p<0.05)
(3) Patient satisfaction- high level with service and no significant differences between groups. Duration of
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FU 6 months. Substantial losses to follow up. Subgroup analysis of % controlled blood pressure, therefore
not included in analysis. Reason for exclusion: no blood pressure data
Bond 1984 Non-randomised trial of clinical pharmacologist nurse clinician improving drug documentation, for blood
pressure control and rheumatology/renal screening. Excluded: no BP outcome data
Borbolla 2007 Participants were not patients with a diagnosis of hypertension
Bosworth 2009 Patient education and provider decision support to control blood pressure in primary care: A cluster ran-
domized trial. Excluded as no usual care arm
Broege 2001 40 hypertensive men and women randomly assigned to ”home“ self measurement with subsequent manage-
ment and medication change compared to ”clinic“ group where medication adjusted based upon readings
taken by project nurse.
Reasons for exclusion:
1. Includes treated and untreated hypertensive patients. Drug treatments adjusted downward or treatment
initiated depending on BP reading and drug treatment status. Not possible to detect effect of self monitoring
on treated blood pressure alone.
2. No usual care- both groups experienced monitoring- self monitoring at home or nurse monitoring in
clinic
Burke 2005 Participants were volunteers to a research studies unit and thus the setting for the study was not ambulatory
care
Cappuccio 2004 Systematic review of home monitoring. 18 RCTs included- several RCTs excluded from this review that
Cappucion included. These are (with reasons why excluded from this review in brackets):
Binstock- no usual care group included.
Stahl- non randomised trial, patients allocated ”sequentially“.
Midanik-
Caro 1998 Non-randomised trial. Observational study of compliance and persistance with therapy, excluded for these
reasons
Carter 2008 Quasi randomised trial. No proper control group due to presence or abscence of clinical pharmacists and
due to education intervention given to physicians and patients in control group
Celis 1998 A randomised controlled trial protocol comparing self measurement of blood pressure against conventional
blood pressure measurement. Protocol of trial. Excluded: no results reported
Chabot 2003 Not an RCT
Charlesworth 1984 Quasi randomised trial. Patients assigned random numbers and then rank ordered. The first 32 were given
intervention, the next 22 were in the control group. Intervention was of stress management outcome SBP
and DBP was significantly reduced in the stress management group. Excluded: intervention and wasn’t
properly randomised
Consoli Randomised trial of computer assisted programme intervention was educational. Outcome knowledge
increased at two months in intervention group compared to control. Excluded as no outcome on blood
pressure or process of care reported
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Consoli SM, Ben2 Randomised trial of computer assisted programme intervention was educational. Outcome knowledge
increased at two months in intervention group compared to control. Excluded as no outcome on blood
pressure or process of care reported
Consoli SM, Ben3 Randomised trial of computer assisted programme intervention was educational. Outcome knowledge
increased at two months in intervention group compared to control. Excluded as no outcome on blood
pressure or process of care reported
Cranney 1999 Non-randomised trial 9 pairs of practices matched by means of overall blood pressure control and then
randomised to eductional intervention directed to health professionals in the practice. The outcome was a
stated threshold for blood pressure control. Excluded because of non-randomised trial design
De Luca 2005 Not an RCT as GPs outside the netwrok could not be randomised
Den 2004 Control group did not receive usual care. Had a fixed drug regimen as part of usual care
Denver 2003 120 Type 2 diabetic patients with uncontrolled hypertension (BP >140/90) randomised to usual GP care
or nurse-led outpatient care. Nurse led care associated with improved systolic blood pressure. Reasons for
exclusion: (1) patients allocated by means of alternation rather than randomisation (2) setting
Djerassi 1990 Non-randomised trial, before/after design. Intervention was based in factories program of follow-up treat-
ment by planned doctor and nurse versus usual care by family doctor in other factories. Outcomes number
of percentage of people treated with an intervention group was greater
Dusing 1998 Observational study of 1603 patients in 320 private practices in Germany. Investigated change in antihy-
pertensive therapy within six months of start of study. Inadequate BP control most important reason for
change in 48.4% of patients in the cohort, others include: adverse effects 30.1%, patient dissatisfaction
20%, non-compliance 16.8%, cost 4.9%
Elmer 2006 Participants were patients with pre-hypertension and not patients with hypertension
Erickson 1997 A non-randomised trial of pharmacist care which involved reviewing medical records, taking drug history,
assessing patients specific drug issues, concerns about taking drugs, lifestyle, compliance and knowledge all
direct to the patient. Outcomes SBP and DBP were reduced in the group who received a pharmacist’s care
at 5 months. Quality of life measures were the same. Trial excluded because it was not randomised
Flack 1995 Observational study reporting adherence rates with different classes of anti-hypertensive agents
Flack 2000 Randomised trial of slow versus fast titration of blood pressure lowering drugs
Foote 1983 Quasi randomised controlled trial. Four interventions, screening and referral to physician, referral to physi-
cian and semi-annual follow-up, referral to physician and more frequent follow-up, and on-site treatment.
Outcome was the number of people under treatment, control and proved in the last three groups
Fu 2005 No English translation could be found.
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Girvin 1999 A randomised trial cross-over design of single versus twice a day Enalapril. The outcomes were of compliance
which increased with the single dose medication and blood pressure control which is better in the twice a day
medication group. Reason for exclusion, adherence randomised trial, included in the adherence systematic
review
Godley 2003 Evaluation of a quality improvement programme for hypertension management. Intervention consisted of
educatinghealthcare providers and recommending appropriate pharmacotherapy for compelling indications.
30,721 hypertensive patients identified from pharmacy claims, 417 patients randomly selected for note
review. Overall level of blood pressure control stated to have improved from 37.2% to 49.2% at follow up.
Reason for exclusion: not a randomised study; no comparison group
Goldstein 2005 Not an RCT to test an intervention to improve blood pressure control
Gonzalez-Fernandez Parallel, individuals, hospitalised for ”non-hypertensive related diseases) in a single hospital, Puerto Rico.
60 treated hypertensives, 55% women, mean age 59 years. (1) In-hospital education- 4 educational inter-
ventions: “knowing high BP” by a physician; “diet and high BP” by a dietician; “exercise and high BP” by a
health educator; “medications and compliance in high BP” by physician and pharmacy student. (2) Usual
care. (1) Blood pressure control- SBP and DBP improved in (E) 137mmHg versus (C) 154mmHg (p=0.
005), diastolic (E) 89mmHg versus 98mmHg (p=0.006)
(2) Compliance (direct questioning and pill count)- adherence improved by 66% in the intervention group
compared to 16% in usual care group (p=0.04). Reason for exclusion: hospital-based RCT
Duration of FU 8 weeks
Grimm A randomised trial of four different class of anti-hypertensive agents and quality of life. Excluded: no data
on BP control, no interventions other than different classes of anti-hypertensive drugs
Hatcher 1986 Factorial randomised trial of health education intervention. Three levels of intervention medication sched-
ules, diet, appointment keeping, family member, reinforcements and small group meeting. Excluded as
intervention was based on ? ? education and no outcomes on blood pressure control in the process of care
Herbert 2004 2x2 factorial RCT of 28 peer learning groups involving 200 family physicians in British Columbia, Canada.
Interventions: personalised prescribing feedback relating to hypertension; case-based educational module.
Evidence-based prescribing improved in both groups (increase in thiazide prescribing as first line agents).
Reason for exclusion: no blood pressure outcomes reported
Hyman Questionnaire study self reported physician practice excluded for that reason
Inui 1976 Before/after study intervention with tutor physician educating patients regarding their hypertension. Ex-
cluded: not a randomised trial
Iso 1996 Randomised trial of health education advice (non-pharmacological) follow-up was at 6 months and one
and half years. Excluded: intervention was based around health education/counselling advice
Iso H, Randomised trial of health education classes to patients. Excluded as intervention was non-pharmacological
advice
Jennett 1986 RCT of continuing medical education in the context of treatment of hypertension. Intervention focused on
three learning objectives: 1) physicians reschedule diagnosed hypertensive patients (aged 50 years or older)
not as yet in control, to be seen at least every month until controlled; 2) physicians take blood pressure of
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hypertensive patients in the supine position and also within one minute after standing on every visit and
the patient’s position is recorded with their blood pressure record; 3) physicians ask patients who have not
yet got controlled blood pressure about their compliance in taking prescribed medication and record the
answer. Two educational formats used: 1) six to eight page educational newsletters; 2) small group discussion.
Behaviour change improvement scores with the intervention group compared to control. Behaviour was
sustained 12 months post education. Reason for exclusion: no blood pressure data reported
Kawachi 1991 Non-randomised trial. Cost effectiveness analysis.
Krishan 1979 Non-randomised trial of nurse practitioner and integrated physician supervised management in community
hypertension clinics versus usual care. No difference in outcome of blood pressure control
Lee 2006 Participants were 200 community-based patients aged 65 years or older taking at least 4 chronic medications
and not specifically patients with hypertension
Levine 2003 RCT of community health workers providing less intensive care (education, counselling and information
about gaining access to free ongoing care in the community) versus more intensive care (all components
of less intensive intervention plus additional home visits, further educational messages and social support
mobilization through family members) . At 40 months follow up, both groups experienced improvement
in blood pressure control (significant within group difference from baseline blood pressure readings). Less
intensive group had greater blood pressure control compared to more intensive group but difference was
not significant. Reason for exclusion: no usual care group
Lewis 1967 Randomised trial of nurse clinics versus usual care in outpatient clinic. The population included patients
with Hypertension and Atherosclerotic Disease, Obesity, Arthritis and Psychophysiological Disorders. The
outcomes are preferences for care, costs and process of care in terms of examinations and investigations.
Excluded: no data on process or outcome of blood pressure care
Liehr 2006 This study examined the blood pressure (BP)-lowering effect of adding story-centered care (i.e., carefully
attending to another’s narrative) to standard lifestyle intervention (i.e., exercise training and nutrition
counselling) and thus was a trial of a non-pharmacological treatment
Linjer 1997 Non-randomised trial. Discussion paper regarding percentage of patients eligible in randomised trials gen-
erally at low risk in trial participants
Littenberg 1990 Non-randomised trial. Cost effectiveness study of increased blood pressure
Marquez 2000 Randomised trial interventionbeinghealth education through group sessionswith postal back-up.Outcomes
were compliance with blood pressure medication. Excluded as no outcome in terms of blood pressure control
reported
Mashru 1997 Before after study of interpractice audit following educational programme concerning diagnosis and man-
agement of hypertension. Six general practices in NWLondon, UK, 750 hypertensive patients. At two years
follow up, two thirds of patients remained “uncontrolled” (BP<160/90)
McDowell 1989 Nonhypertensive patients registeredwith a large family practice (Canada). Interventions: computer reminder
to GP, letter to patient, nurse telephone call to patient. Outcome was whether blood pressure was checked
or not. Effect of reminders was “modest”
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McInnes 1995 Non-randomised trial two patients were matched and then randomised to it. Shared care or clinical care.
The intervention was computerised shared care versus hospital clinical care in outpatients departments. The
outcome showed there were less drop-outs for shared care and they were better adequately used in terms
of patient management in shared care compared to usual care. Shared care was more cost effective. Blood
pressure control was similar in both groups
McKenney 1973 A pharmacist intervention directly at patients improved knowledge compliance with medication and blood
pressure control, however not randomised properly. Patients assigned consecutive numbers then randomised
according whether they had odd or even numbers
Mitchell 2004 Quasi-randomisation study. Randomisation occurred at the level of practice but data collected at the level
of the patient. Patients not randomised. Thus patient numbers increase from baseline to follow-up
Mitchell 2005 Quasi-randomisation study. Randomisation occurred at the level of practice but data collected at the level
of the patient. Patients not randomised. Thus patient numbers increase from baseline to final
Morisky 2002 Control group did not receive usual care but rather were receiving the CHIP programme
Murray 1988 Not hypertensive patients. Population: persons “at risk” of developing hypertension. Intervention: direct
mail to prompt attendance at clinic, either single, multiple or no mail. Outcome: number of patients who
had a blood pressure checked or discussed with their physician
New 2003 Specialist nurse-led clinic in a single outpatient clinic in Salford, UK. Population: diabetic patients receiving
hospital-based care. Comparison group: usual hospital care. Outcome: improvement in blood pressure and
hyperlipidemia targets acheived with intervention. Reason for exclusion: hosptial-based, (2) diabetic patients
Pheley 1995 Observational study of nurse based hypertension clinic with no comparison group
Putnam 1989 40 family physicians from the Dalhousie University Division of Continuing Medical Education separated
into 3 groups according to extent of involvement in establishing essential criteria for hypertension manag-
ment. No difference in control of blood pressure in these family physician’s patients at 18 months follow
up. Reason for exclusion: non randomised trial
Ramsay 1996 Non-randomised trial. Discussion paper.
Roumie 2006 No proper control group. Providers who cared for eligible patients were randomly assigned to receive an
e-mail with a Web-based link to the Seventh Report of the Joint National Committee on the Prevention,
Detection, Evaluation and Treatment of High Blood Pressure (JNC 7) guidelines (provider education);
provider education and a patient-specific hypertension computerized alert (provider education and alert); or
provider education, hypertension alert, and patient education, in which patients were sent a letter advocating
drug adherence, lifestyle modification, and conversations with providers (patient education)
Simon 2005 Quasi-randomised trial: Randomisation occurred at the level of practice but data collected at the level of
the patient. Patients not randomised. Thus patient numbers increase from baseline to final
Staessen 2004 Randomised trial of treatment based on (1) BP measured at home (3 consecutive measurements twice daily)
versus (2) BP measured at physician’s office (average of 3 consecutive readings taken by physician during
practice hours).
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Reason for exclusion:
(1) Assessed selfmonitoring in the context “as guides to initiate and titrate antihypertensive drug treatment”.
(2) Treated and untreated patients included.
At follow-up (median 350 days), more home BP than office BP patients had stopped antihypertensive drugs
with no difference between groups of patients who had progressed to multiple drug treatment. Final office,
home and 24-hour ambulatory BP measurements were higher in the home BP group than in the office BP
group
Stahl 1984 Non-randomised trial. Self and family read bloodpressuremonitoring groups plus nurse education. Excluded
because of non-randomised study
Statson 1977 Non-randomised trial. Examining the cost effectiveness of treatment of hypertension
Stephenson 1999 Non-randomised trial.
Thomas 2006 No outcome data specific to hypertensive patients available. Corresponding author emailed and no response
Trocha 1999 91 hypertensive type 1 diabetic patients with overt diabetic nephropathy followed for 10 years. Intensfied
versus routine antihypertensive treatment. Blood pressure control and survival improved in the intensified
group. Reason for exclusion: non randomised study
Tu 1999 Parallel, individuals 222 attending a “health unit clinic”, carried out in a veteran home in Taiwan, China.
Hypertension, SBP 140 or DBP 90 in untreated patients or treated hypertension patients BP level not
stated. Average age 74.6 years. (1)Medical education group (MEG)-monthlymeeting concerning cognition,
attitude self-care behaviours for hypertension
(2) Health education- same content but delivered every other month group (EOMG). Differences between
groups not clearly reported. Stated that no difference in attitudes and behaviour between groups. Blood
pressure no difference in SBP but higher DBP in EOMG. Between group differences not clearly stated.
Table 3, within group differences all improved for “cognition, behaviours and attitudes” scores and “blood
pressure marking” changes. Duration of FU 6 months. Reason for exclusion: no BP data for both arms of
study reported
UK PDS 1998 Randomised trial of tight less tight blood pressure control. Excluded because its not reporting on process
and organisational issues in hypertension care
van den Hoogen 1990 Non randomised study. “Experimental” study but no mention of randomisation. 15 general practices in
the Netherlands, newly detected patients with hypertension two years prior to start of study aged 36-55
years. Intervention: computer-assisted monitoring system, provides monthly feedback on treatment results,
regular meetings at practices where surveys discussed. Outome: improved surveillance and control of blood
pressure in computer group
Waeber 1999 Randomised trial of compliance in terms of aspirin versus placebo from the HOT randomised controlled
trial
Weiner 1980 Cluster- six “industrial settings” randomised. Ohio county clinics US, SBP>140 or DBP >90 age 19-39,
SBP >150 or DBP >90 age 40-64. (1) Nurse management. Involved reinforcement to take medication,
information about side effects of medications, diet instruction, BP checks, weight checks, education and
counselling regarding “an understanding and acceptance of hypertension”, (2) Usual care. Positive RCT
reported. Experimental patients had better:
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(1) Decreases in maximum SBP (p=0.02)
(2) Average SBP (p=0.02)
(3) % overweight (p=0.01)
(4) Improved knowledge (p=0.002). Duration FU 3months. No difference found formaximum and average
DBP between (E) and (C). Only very brief account of RCT with no details of baseline or follow up blood
pressure. Reason for exclusion: no blood pressure data
Weir 2002 Questionnaire survey a combination of lifestyle medication taking in half outcomes
Wollard 1995 Randomised trial at two levels of intensity, lifestyle advice/counselling from practice nurses. Outcome was
lifestyle and non-pharmacological change in patients. Excluded because intervention was based on non-
pharmacological advice and outcomes included lifestyle changes. Of note intervention was more effective
than usual care
Wyka-Fitzgerald 1984 Randomised trial of nurse education programme directed at patients intervention was non-pharmacological
advice so excluded for this reason
Zernike 1998 Randomised trial of structured patient-centred education programme versus normal information. Outcome
patient knowledge which was increased and structured intervention. Excluded as no outcomes reported on
blood pressure control or process of care
Characteristics of ongoing studies [ordered by study ID]
Bosworth
Trial name or title Bosworth HB, Olsen MK, McCant F, Harrelson M, Gentry P, Rose C, et al. Hypertension Intervention
Nurse Telemedicine Study (HINTS): testing amultifactorial tailored behavioral/educational and amedication
management intervention for blood pressure control. 2007;153(6):918-924
Methods RCT
Participants Patients with hypertension
Interventions Multifactorial tailored behavioral/educational and a medication management intervention for blood pressure
control
Outcomes Blood pressure control.
Starting date 2007-2009
Contact information boswo001@mc.duke.edu
Notes Trial nearing completion
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Carter
Trial name or title A Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control:An effectiveness
study
Methods Cluster Randomized Trial
Participants Patients with hypertension
Interventions Physician/Pharmacist led intervention
Outcomes Blood Pressure Control
Starting date Not known
Contact information barry-carter@uiowa.edu
Notes Duration of the intervention was 6 months. Submitted for publication
Coppola
Trial name or title Improving the primary prevention of stroke in older patients in general practice: a randomized controlled
trial
Methods Practices were randomised by size and location to receive a specific intervention package or not. This included
the use of a scoring system to identify those at particularly high risk. Emphasis was placed on the identification
of risk and the use of interventions targeted on themajor risk factors: Identification and management of raised
blood pressure, smoking cessation, and use of aspirin. Agreement was reached within the practice about the
use of risk scores, and levels of intervention. Control practices received no contact until the casenote review
Participants Elderly patients (aged between 60 to 75 years) registered in 20 general practices in London UK
Interventions Intervention directed at health professionals in general practices. One hour seminar
Outcomes Blood pressure control
Starting date Not known
Contact information pwhincup@sghms.ac.uk
Notes Trial remains unpublished at the time of the current update.
Krieger
Trial name or title SHIP Clinic-Based Program
Methods Not known
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Krieger (Continued)
Participants 1. Patients currently at a participating clinic with a diagnosis of hypertension.
2. Low income.
3. Caucasian or African American.
4. Aged 18 or older
Interventions 1. Patient care co-ordinator at each clinic.
2. Computerised tracking system.
3. Linkage with outreach workers.
4. Linkage with community-based resources
Outcomes 1. Mean systolic and diastolic blood pressure.
2. Non-pharmacological behaviour change
3. Control of blood pressure
Starting date Not known
Contact information James Krieger
James.krieger@METROC.GOV
Notes RCT complete, anticipated publication in 2003. However, author could not be contacted at the above email
addresses at the time of the current update
Logan
Trial name or title Mobile phone-based remote patient monitoring system for management of hypertension in diabetic patients
Methods Phase 1 involved a series of focus-group meetings with patients and primary care providers to guide the
system’s development
Participants In Phase 2, 33 diabetic patients with uncontrolled ambulatory hypertension were enrolled in a 4-month pilot
study, using a before-and-after design to assess its effectiveness in lowering BP, its acceptability to users, and
the reliability of home BP measurements
Interventions Home BP tele-management system that actively engages patients in the process of care
Outcomes Mean systolic and diastolic blood pressure and control of blood pressure
Starting date Not known
Contact information LOGAN@lunenfeld.ca
Notes In final year of RCT, Results available in June 2010
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Zarnke
Trial name or title Not known
Methods Not known
Participants Patients with uncontrolled hypertension
Interventions Patient-directed self measurement
Outcomes 1. Blood pressure measurement 2. Mean systolic and diastolic blood pressure 3. Blood pressure control
Starting date Not known
Contact information kelly.zarnke@lhsc.on.ca
Notes RCT complete, data being analysed. Remians unpublished and author remains uncontactable
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D A T A A N D A N A L Y S E S
Comparison 1. Active intervention versus control
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Self monitoring (systolic blood
pressure)
12 2492 Mean Difference (IV, Fixed, 95% CI) -2.53 [-3.73, -1.34]
2 Self monitoring (diastolic blood
pressure)
14 2598 Mean Difference (IV, Fixed, 95% CI) -1.81 [-2.39, -1.23]
3 Self monitoring (BP control) 6 2237 Odds Ratio (M-H, Fixed, 95% CI) 0.97 [0.81, 1.16]
4 Patient education (systolic blood
pressure)
11 8901 Mean Difference (IV, Fixed, 95% CI) -0.57 [-1.22, 0.08]
5 Patient education (diastolic
blood pressure)
13 9050 Mean Difference (IV, Fixed, 95% CI) 0.46 [0.07, 0.86]
6 Patient education (BP control) 7 7950 Odds Ratio (M-H, Fixed, 95% CI) 0.83 [0.75, 0.91]
7 Physician education (systolic
blood pressure)
7 9998 Mean Difference (IV, Fixed, 95% CI) -0.43 [-1.07, 0.22]
8 Physician education (diastolic
blood pressure)
7 9998 Mean Difference (IV, Fixed, 95% CI) 0.59 [0.21, 0.96]
9 Physician education (BP control) 7 21144 Odds Ratio (M-H, Fixed, 95% CI) 0.85 [0.80, 0.90]
10 Health professional led care
(systolic blood pressure)
10 2235 Mean Difference (IV, Fixed, 95% CI) -2.52 [-3.77, -1.27]
11 Health professional led care
(diastolic blood pressure)
11 2682 Mean Difference (IV, Fixed, 95% CI) -1.49 [-2.02, -0.96]
12 Health professional led care
(BP control)
6 1506 Odds Ratio (M-H, Fixed, 95% CI) 0.30 [0.24, 0.38]
13 Organisation/protocol driven
care (systolic blood pressure)
9 7664 Mean Difference (IV, Fixed, 95% CI) -6.00 [-8.81, -7.18]
14 Organisation/protocol driven
care (diastolic blood pressure)
9 7664 Mean Difference (IV, Fixed, 95% CI) -4.27 [-4.65, -3.89]
15 Organisation/protocol driven
care (BP Control)
7 11998 Odds Ratio (M-H, Fixed, 95% CI) 0.45 [0.41, 0.48]
16 Appointment reminder
(outcome: lost to follow up at
clinic)
6 1704 Odds Ratio (M-H, Fixed, 95% CI) 0.41 [0.32, 0.51]
17 Appointment reminder
(systolic blood pressure)
2 787 Mean Difference (IV, Fixed, 95% CI) -4.56 [-6.31, -2.81]
18 Appointment reminder
(diastolic blood pressure)
2 787 Mean Difference (IV, Fixed, 95% CI) -0.53 [-2.01, 0.95]
19 Appointment reminder
(outcome: blood pressure
control)
2 767 Odds Ratio (M-H, Fixed, 95% CI) 0.54 [0.41, 0.73]
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Analysis 1.1. Comparison 1 Active intervention versus control, Outcome 1 Self monitoring (systolic blood
pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 1 Self monitoring (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Artinian 2001 6 -25 (13.8) 9 1 (14.1) 0.7 % -26.00 [ -40.38, -11.62 ]
Bailey 1998 31 -8 (19.4) 29 -13 (19) 1.5 % 5.00 [ -4.72, 14.72 ]
Carnahan 1975 49 -18 (18.5) 48 -10.5 (14.9) 3.2 % -7.50 [ -14.18, -0.82 ]
Friedman 1996 110 -11 (13.4) 123 -10.6 (13.7) 11.8 % -0.40 [ -3.88, 3.08 ]
Halme 2005 113 -7.7 (15.3) 119 -4.5 (16.2) 8.7 % -3.20 [ -7.25, 0.85 ]
McManus 2005 189 -8.9 (15.3) 211 -6.6 (16.2) 15.0 % -2.30 [ -5.39, 0.79 ]
Mehos 2000 18 -17.1 (15.8) 18 -7 (13.9) 1.5 % -10.10 [ -19.82, -0.38 ]
Midanik 1991 74 -1 (15.8) 72 1 (17.3) 4.9 % -2.00 [ -7.38, 3.38 ]
Rogers 2001 56 -4.9 (13.5) 55 -0.1 (13.4) 5.7 % -4.80 [ -9.80, 0.20 ]
Rudd 2004 74 -14.2 (17.8) 76 -5.7 (18.4) 4.3 % -8.50 [ -14.29, -2.71 ]
Soghikian 1992 200 -1.5 (13.9) 190 1.8 (17) 14.9 % -3.30 [ -6.39, -0.21 ]
Vetter 2000 296 -21 (14.5) 326 -20.5 (14.3) 27.8 % -0.50 [ -2.77, 1.77 ]
Total (95% CI) 1216 1276 100.0 % -2.53 [ -3.73, -1.34 ]
Heterogeneity: Chi2 = 26.79, df = 11 (P = 0.005); I2 =59%
Test for overall effect: Z = 4.15 (P = 0.000033)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Active intervention versus control, Outcome 2 Self monitoring (diastolic blood
pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 2 Self monitoring (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Artinian 2001 6 -14 (8.7) 9 -2 (9.9) 0.4 % -12.00 [ -21.50, -2.50 ]
Bailey 1998 31 -6 (2.8) 29 -4 (2.8) 16.8 % -2.00 [ -3.42, -0.58 ]
Carnahan 1975 49 -10.4 (9.8) 48 -10.4 (9.8) 2.2 % 0.0 [ -3.90, 3.90 ]
Friedman 1996 110 -5.2 (8.3) 123 -0.8 (8) 7.7 % -4.40 [ -6.50, -2.30 ]
Halme 2005 113 -3 (7) 119 -2.3 (8.7) 8.2 % -0.70 [ -2.73, 1.33 ]
Haynes 1976 20 -5.4 (5.7) 18 -1.9 (5.4) 2.7 % -3.50 [ -7.03, 0.03 ]
Johnson 1978 34 -8.5 (8.1) 34 -7.5 (11.3) 1.5 % -1.00 [ -5.67, 3.67 ]
McManus 2005 189 -5.7 (8.2) 211 -4.6 (8.6) 12.5 % -1.10 [ -2.75, 0.55 ]
Mehos 2000 18 -10.5 (10.4) 18 -3.8 (9.3) 0.8 % -6.70 [ -13.15, -0.25 ]
Midanik 1991 74 1 (9.4) 72 1 (8.4) 4.0 % 0.0 [ -2.89, 2.89 ]
Rogers 2001 56 -1.9 (10) 55 2.1 (10) 2.4 % -4.00 [ -7.72, -0.28 ]
Rudd 2004 74 -6.5 (9.9) 76 -3.4 (7.8) 4.1 % -3.10 [ -5.96, -0.24 ]
Soghikian 1992 200 0.1 (9.1) 190 1.7 (10.2) 9.1 % -1.60 [ -3.52, 0.32 ]
Vetter 2000 296 -13.2 (7.2) 326 -11.9 (6.9) 27.4 % -1.30 [ -2.41, -0.19 ]
Total (95% CI) 1270 1328 100.0 % -1.81 [ -2.39, -1.23 ]
Heterogeneity: Chi2 = 20.71, df = 13 (P = 0.08); I2 =37%
Test for overall effect: Z = 6.09 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Active intervention versus control, Outcome 3 Self monitoring (BP control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 3 Self monitoring (BP control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Baqu A¨o¨ 2005 345/487 380/570 41.6 % 1.21 [ 0.94, 1.58 ]
Earp 1982 29/74 16/47 4.8 % 1.25 [ 0.58, 2.68 ]
Halme 2005 80/113 100/119 11.6 % 0.46 [ 0.24, 0.87 ]
Pierce 1984 15/55 7/29 2.7 % 1.18 [ 0.42, 3.32 ]
Rogers 2001 36/60 35/61 5.7 % 1.11 [ 0.54, 2.30 ]
Vetter 2000 100/296 131/326 33.6 % 0.76 [ 0.55, 1.05 ]
Total (95% CI) 1085 1152 100.0 % 0.97 [ 0.81, 1.16 ]
Total events: 605 (Treatment), 669 (Control)
Heterogeneity: Chi2 = 10.95, df = 5 (P = 0.05); I2 =54%
Test for overall effect: Z = 0.34 (P = 0.73)
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Analysis 1.4. Comparison 1 Active intervention versus control, Outcome 4 Patient education (systolic
blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 4 Patient education (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Billault 1995 82 -2.7 (16.5) 85 -1.6 (14.6) 1.9 % -1.10 [ -5.83, 3.63 ]
Burrelle 1986 8 -13.2 (16) 8 -5.8 (14.8) 0.2 % -7.40 [ -22.50, 7.70 ]
Cakir 2006 30 -8.9 (10.7) 30 1.1 (9) 1.7 % -10.00 [ -15.00, -5.00 ]
Fielding 1994 74 -10.9 (19.3) 71 -2.4 (19.5) 1.1 % -8.50 [ -14.82, -2.18 ]
Hennessy 2006 3617 -3 (15.6) 3542 -3 (15.7) 80.2 % 0.0 [ -0.73, 0.73 ]
Hunt 2004 135 -9 (11.4) 150 -7 (11.8) 5.8 % -2.00 [ -4.70, 0.70 ]
McKinstry 2006 130 1 (19.7) 131 2 (19.3) 1.9 % -1.00 [ -5.73, 3.73 ]
Muhlhauser 1993 86 -8 (13.5) 74 -3 (13.9) 2.3 % -5.00 [ -9.26, -0.74 ]
Roca-Cusachs 1991 84 -16.7 (18.5) 111 -18 (21.6) 1.3 % 1.30 [ -4.34, 6.94 ]
Watkins 1987 204 -0.2 (18.6) 210 -0.8 (18.6) 3.3 % 0.60 [ -2.98, 4.18 ]
Zismer 1982 26 -13.1 (13.9) 13 2.6 (16.2) 0.4 % -15.70 [ -26.00, -5.40 ]
Total (95% CI) 4476 4425 100.0 % -0.57 [ -1.22, 0.08 ]
Heterogeneity: Chi2 = 37.29, df = 10 (P = 0.00005); I2 =73%
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Active intervention versus control, Outcome 5 Patient education (diastolic
blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 5 Patient education (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Billault 1995 82 1.3 (7.8) 85 -0.1 (11.2) 1.8 % 1.40 [ -1.52, 4.32 ]
Burrelle 1986 8 -4.1 (11.9) 8 -11.2 (13.1) 0.1 % 7.10 [ -5.16, 19.36 ]
Cakir 2006 30 -7 (7.9) 30 1.6 (6.5) 1.2 % -8.60 [ -12.26, -4.94 ]
Fielding 1994 74 -5.6 (9.7) 71 -1.7 (9.8) 1.5 % -3.90 [ -7.07, -0.73 ]
Hennessy 2006 3617 -2 (9.5) 3542 -3 (9.6) 78.8 % 1.00 [ 0.56, 1.44 ]
Hunt 2004 162 -5 (9.9) 150 -3 (10.3) 3.1 % -2.00 [ -4.25, 0.25 ]
McKinstry 2006 130 -4 (10.6) 131 -2 (11.1) 2.2 % -2.00 [ -4.63, 0.63 ]
Muhlhauser 1993 86 -5 (7.3) 74 -2 (8.2) 2.6 % -3.00 [ -5.42, -0.58 ]
Roca-Cusachs 1991 84 -7.6 (9.5) 111 -9.5 (11.7) 1.7 % 1.90 [ -1.08, 4.88 ]
Tanner 1981 15 -3.7 (6.9) 15 -3.9 (6.9) 0.6 % 0.20 [ -4.74, 5.14 ]
Watkins 1987 204 0.3 (9.3) 210 -0.1 (9.3) 4.8 % 0.40 [ -1.39, 2.19 ]
Webb 1980 37 -6.8 (9) 55 -3.5 (8.4) 1.2 % -3.30 [ -6.95, 0.35 ]
Zismer 1982 26 -8.2 (8.9) 13 0.5 (10.9) 0.3 % -8.70 [ -15.54, -1.86 ]
Total (95% CI) 4555 4495 100.0 % 0.46 [ 0.07, 0.86 ]
Heterogeneity: Chi2 = 65.69, df = 12 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Active intervention versus control, Outcome 6 Patient education (BP control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 6 Patient education (BP control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Earp 1982 14/41 16/47 1.0 % 1.00 [ 0.42, 2.43 ]
Hennessy 2006 1238/3617 1363/3542 91.2 % 0.83 [ 0.76, 0.92 ]
McKinstry 2006 59/130 60/131 3.3 % 0.98 [ 0.60, 1.60 ]
Morisky 1983 15/44 24/40 1.7 % 0.34 [ 0.14, 0.84 ]
Muhlhauser 1993 74/86 63/74 1.0 % 1.08 [ 0.44, 2.61 ]
Pierce 1984 10/59 9/27 1.0 % 0.41 [ 0.14, 1.17 ]
Sackett 1975 61/80 26/32 0.9 % 0.74 [ 0.27, 2.07 ]
Total (95% CI) 4057 3893 100.0 % 0.83 [ 0.75, 0.91 ]
Total events: 1471 (Treatment), 1561 (Control)
Heterogeneity: Chi2 = 6.54, df = 6 (P = 0.37); I2 =8%
Test for overall effect: Z = 4.02 (P = 0.000058)
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Analysis 1.7. Comparison 1 Active intervention versus control, Outcome 7 Physician education (systolic
blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 7 Physician education (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Coe 1977 60 -19.5 (21.1) 56 -18.3 (27) 0.5 % -1.20 [ -10.06, 7.66 ]
Dickinson 1981 78 -10 (20.9) 33 -11 (23.8) 0.5 % 1.00 [ -8.35, 10.35 ]
Evans 1986 102 -12.2 (13.7) 81 -13 (19.6) 1.6 % 0.80 [ -4.23, 5.83 ]
Hennessy 2006 3617 -3 (15.6) 3542 -3 (15.7) 79.1 % 0.0 [ -0.73, 0.73 ]
Hetlevik 1999 816 -2.3 (19.1) 1023 -0.8 (18.3) 14.0 % -1.50 [ -3.22, 0.22 ]
Montgomery 2000 199 -3 (18.1) 130 1 (20.3) 2.2 % -4.00 [ -8.30, 0.30 ]
Sanders 2002 135 -7.1 (18.5) 126 -0.3 (18.9) 2.0 % -6.80 [ -11.34, -2.26 ]
Total (95% CI) 5007 4991 100.0 % -0.43 [ -1.07, 0.22 ]
Heterogeneity: Chi2 = 13.38, df = 6 (P = 0.04); I2 =55%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Active intervention versus control, Outcome 8 Physician education (diastolic
blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 8 Physician education (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Montgomery 2000 199 -1 (9.1) 130 -2 (10.4) 2.9 % 1.00 [ -1.19, 3.19 ]
Coe 1977 60 -13.4 (13.2) 56 -14.5 (12.8) 0.6 % 1.10 [ -3.63, 5.83 ]
Dickinson 1981 78 -5 (13.9) 33 -4 (14.7) 0.4 % -1.00 [ -6.89, 4.89 ]
Evans 1986 102 1 (6.9) 81 0.7 (8.6) 2.6 % 0.30 [ -2.00, 2.60 ]
Hetlevik 1999 816 -1.8 (9.3) 1023 -1.2 (8.5) 20.5 % -0.60 [ -1.42, 0.22 ]
Sanders 2002 135 -3.4 (10.8) 126 -1.3 (11.5) 1.9 % -2.10 [ -4.81, 0.61 ]
Hennessy 2006 3617 -2 (9.5) 3542 -3 (9.6) 71.1 % 1.00 [ 0.56, 1.44 ]
Total (95% CI) 5007 4991 100.0 % 0.59 [ 0.21, 0.96 ]
Heterogeneity: Chi2 = 15.62, df = 6 (P = 0.02); I2 =62%
Test for overall effect: Z = 3.09 (P = 0.0020)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Active intervention versus control, Outcome 9 Physician education (BP
control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 9 Physician education (BP control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dickinson 1981 14/78 3/16 0.2 % 0.95 [ 0.24, 3.78 ]
Evans 1986 42/102 37/81 0.9 % 0.83 [ 0.46, 1.50 ]
Hennessy 2006 1238/3617 1363/3542 33.5 % 0.83 [ 0.76, 0.92 ]
McAlister 1986 35/319 35/283 1.2 % 0.87 [ 0.53, 1.44 ]
Montgomery 2000 120/199 77/130 1.4 % 1.05 [ 0.67, 1.64 ]
New 2004 1282/2474 1319/2531 23.3 % 0.99 [ 0.88, 1.10 ]
Ornstein 2004 1850/4446 1600/3326 39.6 % 0.77 [ 0.70, 0.84 ]
Total (95% CI) 11235 9909 100.0 % 0.85 [ 0.80, 0.90 ]
Total events: 4581 (Treatment), 4434 (Control)
Heterogeneity: Chi2 = 12.86, df = 6 (P = 0.05); I2 =53%
Test for overall effect: Z = 5.86 (P < 0.00001)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
90Interventions used to improve control of blood pressure in patients with hypertension (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.10. Comparison 1 Active intervention versus control, Outcome 10 Health professional led care
(systolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 10 Health professional led care (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bogden 1998 49 -23 (22.6) 46 -11 (20) 2.1 % -12.00 [ -20.57, -3.43 ]
de Castro 2006 30 -6 (14.7) 34 -1 (14.3) 3.1 % -5.00 [ -12.13, 2.13 ]
Garcia-Pena 2001 345 -6.8 (17.4) 338 -3.5 (17) 23.4 % -3.30 [ -5.88, -0.72 ]
Hawkins 1979 349 -2 (14.1) 280 -2 (10.7) 41.4 % 0.0 [ -1.94, 1.94 ]
Park 1996 23 -12.3 (15.8) 27 0.7 (18.8) 1.7 % -13.00 [ -22.59, -3.41 ]
Schroeder 2005 110 -6.1 (15.7) 94 -4.4 (18.3) 7.0 % -1.70 [ -6.42, 3.02 ]
Solomon 2002 63 -8.2 (15.2) 70 -1.3 (19) 4.6 % -6.90 [ -12.72, -1.08 ]
Sookaneknun 2004 118 -23.3 (17.2) 117 -17.6 (18.6) 7.4 % -5.70 [ -10.28, -1.12 ]
Tobe 2006 48 -24 (13.6) 47 -17 (18.1) 3.7 % -7.00 [ -13.45, -0.55 ]
Tonstad 2007 29 -10 (8.7) 18 -10 (9.2) 5.5 % 0.0 [ -5.30, 5.30 ]
Total (95% CI) 1164 1071 100.0 % -2.52 [ -3.77, -1.27 ]
Heterogeneity: Chi2 = 23.46, df = 9 (P = 0.01); I2 =62%
Test for overall effect: Z = 3.96 (P = 0.000075)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Active intervention versus control, Outcome 11 Health professional led care
(diastolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 11 Health professional led care (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bogden 1998 49 -11 (9.4) 46 -3 (10.2) 1.8 % -8.00 [ -11.95, -4.05 ]
de Castro 2006 30 -3 (10.4) 34 -1 (10.4) 1.1 % -2.00 [ -7.11, 3.11 ]
Garcia-Pena 2001 345 -3.7 (9.2) 338 0 (9.6) 14.1 % -3.70 [ -5.11, -2.29 ]
Hawkins 1979 349 -2 (5.3) 280 -2 (4) 52.9 % 0.0 [ -0.73, 0.73 ]
Logan 1979 206 -10 (6.4) 204 -6.1 (7.2) 16.1 % -3.90 [ -5.22, -2.58 ]
Park 1996 23 -4.6 (8.5) 27 0.4 (9.3) 1.1 % -5.00 [ -9.94, -0.06 ]
Schroeder 2005 127 -3.3 (9.6) 114 -3.2 (9.7) 4.7 % -0.10 [ -2.54, 2.34 ]
Solomon 2002 63 -4.4 (11.4) 70 -3.8 (11) 1.9 % -0.60 [ -4.42, 3.22 ]
Sookaneknun 2004 118 -14.2 (12.1) 117 -11.7 (12.2) 2.9 % -2.50 [ -5.61, 0.61 ]
Tobe 2006 48 -1.6 (10.6) 47 -0.8 (10.9) 1.5 % -0.80 [ -5.12, 3.52 ]
Tonstad 2007 29 -3 (6.9) 18 -2 (6.2) 1.9 % -1.00 [ -4.81, 2.81 ]
Total (95% CI) 1387 1295 100.0 % -1.49 [ -2.02, -0.96 ]
Heterogeneity: Chi2 = 52.81, df = 10 (P<0.00001); I2 =81%
Test for overall effect: Z = 5.52 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.12. Comparison 1 Active intervention versus control, Outcome 12 Health professional led care
(BP control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 12 Health professional led care (BP control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bogden 1998 22/49 37/46 8.2 % 0.20 [ 0.08, 0.50 ]
Garcia-Pena 2001 220/345 316/338 45.0 % 0.12 [ 0.08, 0.20 ]
Jewell 1988 5/15 7/19 1.6 % 0.86 [ 0.21, 3.55 ]
Logan 1979 102/204 146/206 28.3 % 0.41 [ 0.27, 0.62 ]
Park 1996 11/23 21/26 4.0 % 0.22 [ 0.06, 0.78 ]
Sookaneknun 2004 40/118 50/117 12.9 % 0.69 [ 0.41, 1.17 ]
Total (95% CI) 754 752 100.0 % 0.30 [ 0.24, 0.38 ]
Total events: 400 (Treatment), 577 (Control)
Heterogeneity: Chi2 = 27.99, df = 5 (P = 0.00004); I2 =82%
Test for overall effect: Z = 9.89 (P < 0.00001)
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Analysis 1.13. Comparison 1 Active intervention versus control, Outcome 13 Organisation/protocol driven
care (systolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 13 Organisation/protocol driven care (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bulpitt 1976 80 -28.8 (17.6) 71 -28.4 (17.1) 2.2 % -0.40 [ -5.94, 5.14 ]
Dickinson 1981 51 -12 (19.7) 33 -11 (23.8) 0.7 % -1.00 [ -10.76, 8.76 ]
Hypertension 1979 2872 -23.6 (16.2) 1718 -15.4 (17.5) 64.1 % -8.20 [ -9.22, -7.18 ]
Hypertension 1979a 811 -38.9 (17.5) 542 -27.2 (18.6) 17.0 % -11.70 [ -13.68, -9.72 ]
Hypertension 1982 438 -52.3 (21.9) 311 -41.7 (21.4) 6.7 % -10.60 [ -13.74, -7.46 ]
Takala 1979 39 -26 (18.4) 36 -29 (17.5) 1.0 % 3.00 [ -5.13, 11.13 ]
Takala 1983 36 -35 (18.5) 34 -38 (18) 0.9 % 3.00 [ -5.55, 11.55 ]
Turnbull 2006 154 0.7 (17.3) 185 1.4 (17.4) 4.8 % -0.70 [ -4.41, 3.01 ]
Wetzels 2007 164 -16 (18.4) 89 -14 (20.1) 2.6 % -2.00 [ -7.04, 3.04 ]
Total (95% CI) 4645 3019 100.0 % -8.00 [ -8.81, -7.18 ]
Heterogeneity: Chi2 = 59.20, df = 8 (P<0.00001); I2 =86%
Test for overall effect: Z = 19.25 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Active intervention versus control, Outcome 14 Organisation/protocol driven
care (diastolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 14 Organisation/protocol driven care (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Bulpitt 1976 80 -9.2 (8.8) 71 -9.4 (8.5) 1.9 % 0.20 [ -2.56, 2.96 ]
Dickinson 1981 51 -6 (9.9) 33 -4 (14.7) 0.4 % -2.00 [ -7.70, 3.70 ]
Hypertension 1979 2872 -10.9 (7.3) 1718 -6.7 (8.1) 65.7 % -4.20 [ -4.67, -3.73 ]
Hypertension 1979a 811 -20.8 (7.2) 542 -14.3 (9) 17.5 % -6.50 [ -7.41, -5.59 ]
Hypertension 1982 438 -30.5 (9.8) 311 -22.9 (12.2) 5.3 % -7.60 [ -9.24, -5.96 ]
Takala 1979 39 -12 (9.2) 36 -15 (8.7) 0.9 % 3.00 [ -1.05, 7.05 ]
Takala 1983 36 -11 (9.2) 34 -16 (9) 0.8 % 5.00 [ 0.74, 9.26 ]
Turnbull 2006 154 -0.1 (7.7) 185 0 (7.7) 5.3 % -0.10 [ -1.75, 1.55 ]
Wetzels 2007 164 -10 (10.4) 89 -9 (9.7) 2.2 % -1.00 [ -3.57, 1.57 ]
Total (95% CI) 4645 3019 100.0 % -4.27 [ -4.65, -3.89 ]
Heterogeneity: Chi2 = 111.36, df = 8 (P<0.00001); I2 =93%
Test for overall effect: Z = 22.11 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Active intervention versus control, Outcome 15 Organisation/protocol driven
care (BP Control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 15 Organisation/protocol driven care (BP Control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Dickinson 1981 15/51 3/16 0.2 % 1.81 [ 0.45, 7.27 ]
Fletcher 1975 36/74 33/70 0.8 % 1.06 [ 0.55, 2.04 ]
Hypertension 1979 1925/5485 3077/5455 95.3 % 0.42 [ 0.39, 0.45 ]
Sackett 1975 67/87 23/28 0.4 % 0.73 [ 0.25, 2.16 ]
Takala 1983 49/71 57/69 0.9 % 0.47 [ 0.21, 1.04 ]
Turnbull 2006 126/154 130/185 1.0 % 1.90 [ 1.14, 3.19 ]
Wetzels 2007 49/164 34/89 1.5 % 0.69 [ 0.40, 1.19 ]
Total (95% CI) 6086 5912 100.0 % 0.45 [ 0.41, 0.48 ]
Total events: 2267 (Treatment), 3357 (Control)
Heterogeneity: Chi2 = 46.94, df = 6 (P<0.00001); I2 =87%
Test for overall effect: Z = 21.38 (P < 0.00001)
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Analysis 1.16. Comparison 1 Active intervention versus control, Outcome 16 Appointment reminder
(outcome: lost to follow up at clinic).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 16 Appointment reminder (outcome: lost to follow up at clinic)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ahluwalia 1996 8/53 6/54 2.2 % 1.42 [ 0.46, 4.42 ]
Barnett 1983 1/63 28/52 13.0 % 0.01 [ 0.00, 0.11 ]
Bloom 1979 12/27 20/27 4.8 % 0.28 [ 0.09, 0.88 ]
Cummings 1985 70/486 129/487 47.4 % 0.47 [ 0.34, 0.65 ]
Fletcher 1975 12/74 26/70 9.6 % 0.33 [ 0.15, 0.72 ]
Krieger 1999 51/146 88/165 23.1 % 0.47 [ 0.30, 0.74 ]
Total (95% CI) 849 855 100.0 % 0.41 [ 0.32, 0.51 ]
Total events: 154 (Treatment), 297 (Control)
Heterogeneity: Chi2 = 16.91, df = 5 (P = 0.005); I2 =70%
Test for overall effect: Z = 7.66 (P < 0.00001)
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Analysis 1.17. Comparison 1 Active intervention versus control, Outcome 17 Appointment reminder
(systolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 17 Appointment reminder (systolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Contreras 2005 172 -22.4 (14.6) 182 -22.1 (11.5) 40.5 % -0.30 [ -3.05, 2.45 ]
Contreras 2005 184 -31.6 (12.4) 182 -22.1 (11.5) 51.0 % -9.50 [ -11.95, -7.05 ]
Marquez 2004 34 -19.1 (13.3) 33 -23.8 (11.7) 8.5 % 4.70 [ -1.29, 10.69 ]
Total (95% CI) 390 397 100.0 % -4.56 [ -6.31, -2.81 ]
Heterogeneity: Chi2 = 34.02, df = 2 (P<0.00001); I2 =94%
Test for overall effect: Z = 5.11 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.18. Comparison 1 Active intervention versus control, Outcome 18 Appointment reminder
(diastolic blood pressure).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 18 Appointment reminder (diastolic blood pressure)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Contreras 2005 184 -19.8 (32.9) 182 -12.7 (9.6) 8.9 % -7.10 [ -12.05, -2.15 ]
Contreras 2005 172 -12.9 (6.6) 182 -12.7 (9.6) 75.1 % -0.20 [ -1.91, 1.51 ]
Marquez 2004 34 -10.7 (9.1) 33 -12.3 (6.1) 16.0 % 1.60 [ -2.10, 5.30 ]
Total (95% CI) 390 397 100.0 % -0.53 [ -2.01, 0.95 ]
Heterogeneity: Chi2 = 8.17, df = 2 (P = 0.02); I2 =76%
Test for overall effect: Z = 0.70 (P = 0.48)
Test for subgroup differences: Not applicable
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Analysis 1.19. Comparison 1 Active intervention versus control, Outcome 19 Appointment reminder
(outcome: blood pressure control).
Review: Interventions used to improve control of blood pressure in patients with hypertension
Comparison: 1 Active intervention versus control
Outcome: 19 Appointment reminder (outcome: blood pressure control)
Study or subgroup Treatment Control Odds Ratio Weight Odds Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Contreras 2005 66/180 95/180 48.0 % 0.52 [ 0.34, 0.79 ]
Contreras 2005 62/160 95/180 43.7 % 0.57 [ 0.37, 0.87 ]
Marquez 2004 12/34 16/33 8.4 % 0.58 [ 0.22, 1.54 ]
Total (95% CI) 374 393 100.0 % 0.54 [ 0.41, 0.73 ]
Total events: 140 (Treatment), 206 (Control)
Heterogeneity: Chi2 = 0.10, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 4.14 (P = 0.000035)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Quality of included randomized trials
Study ID Randomization Allocation concealed Blinding Losses to follow up
Carnahan Method not stated Not stated No 1/50 (E- 2%)
2/50 (C- 4%)
1/50 (E- 2%)
2/50 (C- 4%)
1/50 (E- 2%)
2/50 (C- 4%)
Hawkins Method not stated Not stated No 225/574 (E- 39.2%)
294/574 (C-51.2%)
Evans Method not stated Not stated Yes-
BP check Staff “blind” to
allocation group
5/107 (E- 5%)
10/91 (C- 11%)
Hypertension Detection
and Follow up (HDFP)
Randomisation
done centrally, stratified
by centre (n=14) and en-
Yes, coordinating centre
prepared sealed opaque
envelopes. An envelope
No- neither participant
or clinic blind to ran-
domisation. BPoutcome
967/5485 (E- 17.6%)
938/5422 (C- 17.2%)
status of antihyperten-
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Table 1. Quality of included randomized trials (Continued)
try DBP strata (n=3) was drawn sequentially
and attached to partici-
pant’s data form at the
time of DBP screening.
Envelope opened after
baseline
not blinded sive drug treatment not
known at 1 year
(includes lost to FU/
dead/missing data)
Jewell Method not stated Not stated No 15/17 (E- 12
19/19 (C- 0%)
Cummings “Randomisation list” Not stated Yes 446\486 (E- 8%)
420\487 (C- 14%)
Tanner “Randomly
assigned through a table
of random numbers”
Not stated No 15/15 (E- 0%)
15/15 (C- 0%)
Zismer Not stated Not stated No 26/26 (E- 0%)
13/13 (C- 0%)
Watkins Not stated but stratified
by age, sex, practice and
last recorded BP
Not stated Yes 414/565 (Overall- 27%)
Rogers Randomisation stratified
by # prescription medi-
cations
Yes- to physicians and
clinical research staff but
once completed “open”
No 56/60 (E-7%)
55/61 (C- 10%)
Muhlhauser Randomisation
process for 10 participat-
ing practices. 20 patients
per practice selected by
means of random num-
ber chart
Not stated No 86/100 (E- 14%)
74/100 (C- 26%)
Montgomery Ran-
domisation by means of
random number table by
a researcher not involved
in study. Practices strati-
fied by computer system
used (2 alternative com-
puter systems)
Yes No 202/229 (E 1 12%)
199/228 (E 2- 13%)
130/157 (C- 17%)
Takala Method not stated Not stated No 25/100 (E- 25%)
32/102 (C- 31%)
Sackett Method not stated Not stated Yes Factorial RCT
(1) Convenience
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Table 1. Quality of included randomized trials (Continued)
Augmented 6/114 (E-
5%)
Normal 4/116 (C- 3%)
(2) Mastery learning
Yes 8/115 (E-7)
No 2/115 (C- 2%)
Haynes Minimisation, method
not stated, patients strat-
ified according to impor-
tant prognostic factors in
previous RCT by Sack-
ett20
Not stated Yes 0/20 (E- 0%)
1/19 (C- 5%)
Logan Method not stated Not stated Yes 26/232 (E- 11%)
21/204 (C- 9%)
Johnson Method not stated Not stated Yes Factorial RCT
(1) Self recording of
blood pressure
(E- 34/36- 6%)
(2) Home visits
(C-34/36- 6%)
Brook By means of
“random sampling tech-
niques thatmade the dis-
tribution of family char-
acteristics in each as sim-
ilar as possible”
Not stated No Free care versus 3 forms
of cost-sharing plans.
Blood pressure
outcome:
Free care (E- 134/294,
46%)
Cost share (C-
Earp Method not stated Not stated No 3 arm RCT
Follow up at year 1 and
2
Group 1-
1 year- 74/99, 25%
2 year- 55/99, 44%
Group 2-
1 year- 41/56, 27%
2 year- 39%
Group 3(control)-
1 year- 47/63, 25%
2 year- 38/63, 40%
Martinez-Amenos Method not stated Not stated No No details on losses to
FU provided
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Table 1. Quality of included randomized trials (Continued)
McAllister Practice cluster stratified
by:
1) partners
2) Ethnicity
randomisation by “shuf-
fled deck of cards”
Not stated No 5/30 (E- 17%)
5/30 (C- 17%)
Bogden Randomisation by last
digit of social security
number:
Odd # (E)
Even # (C)
Not stated Yes 1/50 (E- 2%)
4/50 (C- 8%)
Fielding Ran-
domisation by means of
random numbers table
Not stated No 6/80 (E- 7%)
8/79 (C- 10%)
Morisky and Levine Randomisation through
“simple random sam-
pling procedures”
Not stated No Overall 64/400 (16%)
Control of BP
(C)
40/50 (20%) 2 yrs
30/50 (40%) 5 yrs
(E) all 3 intervention
44/50 (12%) 2 yrs
42/50 (16%) 5 yrs
Zarnke Ran-
domisation by means of
computer generated list
in blocks of six. Asym-
metric allocation scheme
(2:1 E:C)
Not stated No 0/20 (E- 0%)
1/11 (C- 9%)
Roca-Cusachs Research nurse “al-
located every patient to
one of the two groups us-
ing a random scale bal-
anced for age and BP”
No Yes 54/138 (E- 39%)
38/149 (C- 26%)
Soghikian Method not stated Not stated No 15/215 (E- 7%)
25/215 (C- 12%)
Billault Method not stated Not stated No 82/101 (E- 19%)
85/99 (C- 14%)
Gullion Method not stated,
physicians stratified ac-
cording to four criteria:
(1) % patients whose
Not stated Yes (1) Medical- 27
(2) Behavioural- 28
(3) Both- 30
(4) Neither- 27
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Table 1. Quality of included randomized trials (Continued)
DBP controlled.
(2) % patients respond-
ing to the survey
(3) Physician’s ethnic
group
(4) Specialty
Friedman Randomized
“using a paired randomi-
sation protocol”
Not stated Yes 23/133 (E- 17%)
11/134 (C- 8%)
Hetlevik Method not stated Not stated No 816/984 (E- 17.1%)
/1255 (C- 18.5%)
Krieger Randomisation based on
computer-generated
random number table
Sealed opaque
envelopes,
sequentially numbered.
Not clear who allocated
individuals to groups
No 146/209 (E- 30.1%)
165/212 (C- 22.2%)
Dickinson Method not stated Not stated No 51/51(E feedback- 0%)
78/78 (E education-
0%)
88/88 (E both- 0%)
33/33 (C neither- 0%)
Barnett Method not stated but
stratified by age and ini-
tial DBP ( 100mmHg or
<100mmHg)
Not stated No 44/63 (E- 30%)
27/52 (C- 48%)
Bulpitt Method not stated Not stated No 25/136 (E- 18%)
36/142 (C- 25%)
Coe Method not stated Not stated Yes 56/56 (E- 0%)
60/60 (C- 0%)
Robson Random number tables Not stated No ?/1620 (E- ?%)
?/1586 (C- ?%)
Bloom Method not stated Not stated Yes 12/27 (E- 44%)
19/27 (C- 74%)
Fletcher Patients were “divided by
meams of a table of ran-
dom numbers”
Not stated Uncertain 144/155 (93%) followed
up at fivemonths.Group
losses to FU not reported
Bailey Method not stated Not stated Yes 29/30 (E- 3%)
31/32 (C- 3%)
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Table 1. Quality of included randomized trials (Continued)
Webb Method not stated Not stated Yes 37/37 (E1-0%)
31/31 (E2-0%)
55/55 (C-0%)
Hamilton Method not stated Not stated No 0/17 (E- 0%)
4/17 (C- 24%)
Park Method not stated Not stated No 5/32 (E- 16%)
6/32 (C- 19%)
Mehos Yes “randomized using a
deck of cards”
Not stated No 2/20 (E- 10%)
3/21 (C- 14%)
Pierce Yes “minimisation” Not stated Yes 59/59 (E health educa-
tion)-0%)
54/57 (E monitor-8.
5%)
Solomon Yes, random number ta-
bles
Not stated No 63/63 (E- 0%)
70/70 (C- 0%)
63/63 (E- 0%)
70/70 (C- 0%)
Burelle Not stated Not stated No 8/8 (E- 0%)
8/8 (C- 0%)
Ahluwalia Yes, computer generated
random number table
Not stated No 8/8 (E- 0%)
8/8 (C- 0%)
Vetter Not stated Not stated No 296/296 (E- 0%)
326/326 (C- 0%)
Bogden Randomisation by last
digit of social security
number:
Odd # (E)
Even # (C)
Not stated Yes 1/50 (E- 2%)
4/50 (C- 8%)
Garcia-Pena Randomisation by com-
puter
Yes Yes 345/345 (E- 0%)
338/338 (C- 0%)
Artinian Method not stated Not stated No 6/6 (E), 9/9 (C)
Midanik Method not stated Not stated No 74/102 (E- 28%) 72/
102 (C- 30%)
New Method not stated Not stated No 99/506 (19.6%) in inter-
vention group compared
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Table 1. Quality of included randomized trials (Continued)
to 132/508 (26.0%) in
control group
Rudd Computer-generated as-
signment
Not stated Blind outcome assess-
ment
74/74 (E-0%) 74/74
(0%)
Ornstein “Bal-
anced adaptive randomi-
sation scheme”, 3 prac-
tice characteristics were:
practice specialty, prac-
tice size and geographical
location
Not stated No- open RCT 4446/4446 (E- 0%)
3326/3326 (C- 0%)
Mc Manus Random number gen-
erator and opaque en-
velopes
Yes No- open RCT 25/ 214 (E-12%)
14/ 227(C-6%)
Baque Unsure as only have
translation of abstract
Unsure as only have
translation of abstract
No- open RCT 133/703 (C- 19%)
487/622 (E- 22%)
Halme Block randomisation
2: 3 OR 3: 2 BLOCKS
Not stated No- open RCT 37/ 269 (14%)
Cakir Centrally via Computer-
generated assignment
Yes Blind outcome assess-
ment
2 /32 (E-6%)
8/38 (C- 21%)
Hunt Computer-generated as-
signment
Yes Blind outcome assess-
ment
Not provided
McKInstry Computer random gen-
eration
Yes Blind outcome assess-
ment
17/ 148 (E-11%)
16/ 146 (C-11%)
Hennesey Comercially available
spreadsheet programme
Not stated Blind participant 1784/5401(E- 33%)
1753/5295(C-33%)
Sookaneknun Simple randomisation
technique?
Not stated Blind participant 5/118 (E-4%)
3/117 (C-3%)
De Castro Stratified by gender
though a computer gen-
erated sequence.
Not stated Double-blind random-
ized clinical trial
4/ 34 (E-12%)
3/ 37 (C-8%)
Tonstad Pre-
sealed numbered consec-
utive envelopes with a 3:
2 ratio for assignment to
intervention or control
groups
Opaque envelopes No 2/ 31 (E-7%)
2/ 20 (C-10%)
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Schroeder Stratified by age and sex
using computer gener-
ated numbers
Yes No- open RCT 18/ 128 (E-14%)
23/ 117 (C-20%)
Wetzels Computer gen-
erated centrally by Trial
Coordinating Centre
Yes Blind treatment
providers
4/168 (E-2%)
1/ 90 (C-1%)
Turnbull Remote computer gen-
erated
Yes No 9/ 170 (E-5%)
8/201 (C-4%)
Marquez Done centrally by two
investigators who were
not field investigators
but method not stated
Not stated No 18/ 52 (E-35%)
19/ 52 (C-36%)
Contreras Done centrally by two
investigators who were
not field investigators
but method not stated
Not stated No 98/636 (total-15%)
No breakdown
Tobe Opaque sealed envelopes
using permuted block
design
No No 2/ 50 (E-4%)
2/ 49 (C-4%)
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor HYPERTENSION explode all trees 11049
#2 blood next pressure in Record Title 4480
#3 hypertens* in Record Title 12324
#4 (#1 or #2 or #3) 18179
#5 MeSH descriptor PHYSICIANS explode all trees 723
#6 MeSH descriptor PATIENT CARE MANAGEMENT explode all trees 9866
#7 MeSH descriptor PATIENT CARE PLANNING explode all trees 1066
#8 MeSH descriptor PATIENT CARE TEAM explode all trees 974
#9 MeSH descriptor PATIENT EDUCATION explode all trees 3728
#10 MeSH descriptor PATIENT PARTICIPATION explode all trees 488
#11 MeSH descriptor AMBULATORY CARE INFORMATION SYSTEMS explode all trees 22
#12 MeSH descriptor FEEDBACK explode all trees 705
#13 MeSH descriptor INFORMATION SYSTEMS explode all trees 1557
#14 MeSH descriptor MANAGEMENT INFORMATION SYSTEMS explode all trees 422
#15 MeSH descriptor Decision Support Systems, Clinical this term only 134
#16 MeSH descriptor Decision Making, Computer-Assisted this term only 110
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#17 MeSH descriptor REMINDER SYSTEMS explode all trees 330
#18 MeSH descriptor GUIDELINES explode all trees 1337
#19 MeSH descriptor MEDICAL AUDIT explode all trees 244
#20 MeSH descriptor MEDICAL RECORDS explode all trees 1404
#21 MeSH descriptor Medical Records Systems, Computerized explode all trees 174
#22 MeSH descriptor PRIMARY HEALTH CARE explode all trees 2048
#23 MeSH descriptor Physicians, Family this term only 329
#24 MeSH descriptor Primary Nursing Care this term only 27
#25 MeSH descriptor NURSE PRACTITIONERS explode all trees 222
#26 MeSH descriptor NURSE CLINICIANS explode all trees 143
#27 MeSH descriptor HEALTH BEHAVIOR explode all trees 6432
#28 remind* in All Text 1310
#29 motiv* in All Text 3973
#30 MeSH descriptor PATIENT CARE this term only 74
#31 MeSH descriptor NURSING CARE this term only 146
#32 MeSH descriptor GUIDELINE ADHERENCE this term only 351
#33 MeSH descriptor AMBULATORY CARE this term only 2716
#34 MeSH descriptor BEHAVIOR THERAPY explode all trees 5550
#35 MeSH descriptor COUNSELING this term only 1531
#36 counsel* in All Text 6293
#37 MeSH descriptor MOTIVATION this term only 1544
#38 self next monitor* in All Text 854
#39 (patient* in All Text near/6 educat* in All Text) 6497
#40 (patient* in All Text near/6 manage* in All Text) 8483
#41 (patient* in All Text near/6 train* in All Text) 3254
#42 (patient* in All Text near/6 teach* in All Text) 1588
#43 (program* in All Text near/6 educat* in All Text) 4243
#44 (program* in All Text near/6 manage* in All Text) 2488
#45 (program* in All Text near/6 train* in All Text) 3521
#46 (program* in All Text near/6 teach* in All Text) 713
#47 self next manag* in All Text 983
#48 (manag* in All Text near/6 hypertension in All Text) 714
#49 (manag* in All Text near/6 blood next pressure in All Text) 264
#50 (monitor* in All Text near/6 blood next pressure in All Text) 2609
#51 (monitor* in All Text near/6 hypertension in All Text) 532
#52 MeSH descriptor HEALTH PROMOTION explode all trees 1618
#53 MeSH descriptor HEALTH EDUCATION explode all trees 5702
#54 reward* in All Text 693
#55 incentiv* in All Text 1031
#56 uncontrol* in All Text 2729
#57 MeSH descriptor SELF CARE this term only 1316
#58 (#5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14) 15288
#59 (#15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23) 5372
#60 (#24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33) 14333
#61 (#34 or #35 or #36 or #37 or #38 or #39 or #40 or #41 or #42 or #43) 30629
#62 (#44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53) 16207
#63 (#54 or #55 or #56 or #57) 5572
#64 (#58 or #59 or #60 or #61 or #62 or #63) 58634
#65 (#4 and #64) 3454
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Appendix 2. MEDLINE search strategy
1 exp Hypertension/ (167533)
2 (blood adj pressure).ti. (33263)
3 hypertens$.ti. (120524)
4 or/1-3 (208545)
5 exp physicians/ (62183)
6 exp Patient Care Management/ (351254)
7 exp Patient Care Planning/ (40740)
8 exp Patient Care Team/ (40160)
9 exp Patient Education/ (50057)
10 exp Patient Participation/ (11975)
11 exp Ambulatory Care Information Systems/ (1034)
12 exp Feedback/ (21503)
13 exp Information Systems/ (98899)
14 exp Management Information Systems/ (27680)
15 exp Decision Support Systems, Clinical/ (2297)
16 exp Decision Making, Computer-Assisted/ (46651)
17 exp Reminder Systems/ (1144)
18 exp Practice Guidelines/ (42659)
19 exp Guidelines as topic/ (64954)
20 exp Medical Audit/ (10918)
21 exp Medical Records/ (56232)
22 exp Medical Records Systems, Computerized/ (13174)
23 exp Primary Health Care/ (49856)
24 exp Physicians, Family/ (11443)
25 exp Primary Nursing Care/ (1868)
26 exp Nurse Practitioners/ (11902)
27 exp Nurse Clinicians/ (6234)
28 exp Health Behavior/ (58847)
29 remind$.tw. (6318)
30 motiv$.tw. (41873)
31 Patient Care/ (4501)
32 Nursing Care/ (24234)
33 Guideline Adherence/ (9258)
34 Ambulatory Care/ (28816)
35 exp Behavior Therapy/ (35585)
36 Counseling/ (21055)
37 counsel$.tw. (40826)
38 Motivation/ (34065)
39 self monitor$.tw. (2518)
40 ((patient$ or program$) adj3 (educat$ or manage$ or train$ or teach$)).tw. (121066)
41 self manage$.tw. (3390)
42 ((manage$ or monitor$) adj3 (hypertension or blood pressure)).tw. (9858)
43 Health Promotion/ (31545)
44 exp Health Education/ (102113)
45 (reward$ or incentive$).tw. (25369)
46 uncontrol$.tw. (17033)
47 Self Care/ (14858)
48 or/5-47 (1087894)
49 4 and 48 (19344)
50 randomized controlled trial.pt. (246660)
51 controlled clinical trial.pt. (76052)
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52 Randomized Controlled Trials/ (51847)
53 random allocation/ (59418)
54 double blind method/ (94259)
55 single blind method/ (11548)
56 or/50-55 (416351)
57 animal/ not human/ (3141649)
58 56 not 57 (390135)
59 clinical trial.pt. (439482)
60 exp clinical trials as topic/ (197049)
61 (clin$ adj25 trial$).ti,ab. (139080)
62 ((singl$ or doubl$ or treble$ or tripl$) adj25 (blind$ or mask$)).ti,ab. (93517)
63 placebos/ (26524)
64 placebo$.ti,ab. (106301)
65 random$.ti,ab. (393128)
66 research design/ (50559)
67 or/59-66 (882479)
68 67 not 57 (818962)
69 58 or 68 (840420)
70 49 and 69 (4661)
Appendix 3. EMBASE search strategy
1 exp hypertension/ (224295)
2 blood pressure.ti. (26788)
3 hypertens$.ti. (86298)
4 or/1-3 (241489)
5 patient referral/ (24316)
6 patient education/ (24921)
7 information system/ (10983)
8 feedback system/ (19306)
9 exp practice guideline/ (132101)
10 medical audit/ (11229)
11 exp primary health care/ (38904)
12 general practitioner/ (28102)
13 nurse practitioner/ (1862)
14 nurse/ (14123)
15 health behavior/ (14365)
16 treatment planning/ (64890)
17 patient counseling/ (18957)
18 behavior therapy/ (19880)
19 motivation/ (16574)
20 self monitoring/ (1519)
21 self care/ (5850)
22 occupational health nursing/ (1062)
23 ((patient$ or program$) adj3 (educat$ or manage$ or train$ or teach$)).tw. (97871)
24 ((manage$ or monitor$) adj3 (hypertension or blood pressure)).tw. (9279)
25 self monitor$.tw. (2307)
26 (reward$ or incentiv$).tw. (19491)
27 or/5-26 (485148)
28 4 and 27 (24029)
29 random$.tw. (360909)
30 factorial$.tw. (7393)
31 (crossover$ or cross over$ or cross-over$).tw. (37365)
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32 placebo$.tw. (103564)
33 (double$ adj blind$).tw. (80760)
34 (singl$ adj blind$).tw. (7017)
35 assign$.tw. (100633)
36 allocat$.tw. (31580)
37 volunteer$.tw. (93637)
38 crossover procedure/ (19892)
39 double blind procedure/ (68037)
40 randomized controlled trial/ (153884)
41 single blind procedure/ (7329)
42 or/29-41 (610829)
43 exp animal/ or nonhuman/ (3022524)
44 exp human/ (6071669)
45 43 not 44 (2552403)
46 42 not 45 (535066)
47 28 and 46 (3668)
WH A T ’ S N E W
Last assessed as up-to-date: 30 July 2008.
Date Event Description
17 February 2010 New search has been performed Substantive update completed
17 February 2010 New citation required and conclusions have changed New citation with change in authors. New data demon-
strate that self-monitoring is associated with moderate
net reduction in systolic and diastolic blood pressure
H I S T O R Y
Protocol first published: Issue 2, 2002
Review first published: Issue 1, 2005
Date Event Description
13 August 2008 Amended Converted to new review format.
2 June 2006 New citation required and conclusions have changed Substantive amendment
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